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Cardiacvascular disease is the top death causing disease worldwide. In recent
years, high-fidelity personalized models of the heart have shown an increas-
ing capability to supplement clinical cardiology for improved patient-specific
diagnosis, prediction, and treatment planning. In addition, they have shown
promise to improve scientific understanding of a variety of disease mechanisms.
However, model personalization by estimating the patient-specific tissue
properties that are in the form of parameters of a physiological model is chal-
lenging. This is because tissue properties, in general, cannot be directly mea-
sured and they need to be estimated from measurements that are indirectly
related to them through a physiological model. Moreover, these unknown tis-
sue properties are heterogeneous and spatially varying throughout the heart
volume presenting a difficulty of high-dimensional (HD) estimation from indi-
rect and limited measurement data. The challenge in model personalization,
therefore, summarizes to solving an ill-posed inverse problem where the un-
known parameters are HD and the forward model is complex with a non-linear
and computationally expensive physiological model.
In this dissertation, we address the above challenge with following contri-
butions. First, to address the concern of a complex forward model, we propose
the surrogate modeling of the complex target function containing the forward
model – an objective function in deterministic estimation or a posterior prob-
ability density function in probabilistic estimation – by actively selecting a set
of training samples and a Bayesian update of the prior over the target function.
The efficient and accurate surrogate of the expensive target function obtained
in this manner is then utilized to accelerate either deterministic or proba-
bilistic parameter estimation. Next, within the framework of Bayesian active
iv
v
learning we enable active surrogate learning over a HD parameter space with
two novel approaches: 1) a multi-scale optimization that can adaptively allo-
cate higher resolution to heterogeneous tissue regions and lower resolution to
homogeneous tissue regions; and 2) a generative model from low-dimensional
(LD) latent code to HD tissue properties. Both of these approaches are inde-
pendently developed and tested within a parameter optimization framework.
Furthermore, we devise a novel method that utilizes the surrogate pdf learned
on an estimated LD parameter space to improve the proposal distribution of
Metropolis-Hastings for an accelerated sampling of the exact posterior pdf.
We evaluate the presented methods on estimating local tissue excitability of a
cardiac electrophysiological model in both synthetic data experiments and real
data experiments. Results demonstrate that the presented methods are able
to improve the accuracy and efficiency in patient-specific model parameter
estimation in comparison to the existing approaches used for model personal-
ization.
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In the past few decades, heart disease has continued to remain the leading
cause of mortality and morbidity worldwide. A recent study published by the
American Heart Association (AHA) in 2017 shows that in the United States
alone cardiovascular disease accounted for nearly 800,000 deaths (about one
in every three deaths) [6].
One of the concerns in the treatment of cardiovascular diseases is that
the treatment and therapy provided to one patient may not work similarly
for another patient with a similar cardiac condition. This can lead to failure
of the treatment method and re-occurrence of the disease. Patients differ
in the anatomy and physiology, and therefore, “one-size-fits-all” treatment
strategies that do not take into account inter-patient variabilities may be less
effective. In this context, computational models of the heart that have the
ability to integrate both generic physics based multi-scale knowledge about the
structure and function of a heart and patient-specific variations in physiology
and anatomy have emerged as an important patient-specific treatment tool.
These personalized computational models of the heart have been shown to
facilitate the planning of surgery such as the coronary bypass graft surgery [65]
or therapy such as the re-synchronization therapy [42, 68], the design and
experimentation of medical devices [48], and the study of the mechanism of
various cardiac diseases [4, 56,76,81,86].
1
CHAPTER 1. INTRODUCTION 2
1.1 Problem Definition
Personalization of a cardiac electrophysiological (EP) model has two major
ingredients: personalization of the anatomy and personalization of the phys-
iology. Advances in medical imaging techniques over the past few decades
have enabled reconstruction of image-based anatomical models at an unprece-
dented level of detail. However, the estimation of subject-specific organ tissue
properties that are in the form of parameters of a physiological model still
suffers from several unresolved critical challenges. First, tissue properties of
an organ typically cannot be directly measured but needs to be estimated
from sparse measurements that are indirectly related to the unknown tissue
properties through a complex nonlinear physiological process. Measurements
obtained with invasive procedure such as optical mapping and catheter map-
ping can be used. However, in addition to suffering from lack of resolution and
precision, these procedures are risky to the patients. Alternately, non-invasive
data measured on the body surface can be utilized. While it is safer to acquire
data non-invasively from the patients, these measurements are more remote
from the unknown tissue properties increasing the challenge in tissue prop-
erties estimation. Additionally, these measurements also contain errors and
uncertainties. Another critical challenge in tissue properties estimation is that
tissue properties are spatially varying throughout the 3D organ where local ab-
normality and heterogeneity often hold important therapeutical implications.
The personalization of organ tissue properties, therefore, translates to an ill-
posed inverse problem in which the forward model contains a computationally
expensive non-linear physiological simulation model and the unknowns are
represented by high-dimensional (HD) model parameters at the resolution of
the discrete organ mesh. For clarity below we summarize the major challenges
associated with physiological model personalization and uncertainty quantifi-
cation into three categories.
• High-dimensional parameter space: Tissue properties are hetero-
geneous and spatially varying throughout the cardiac mesh. Through
discretization of the cardiac mesh, this continuous space of tissue prop-
erties can be expressed with model parameters at the dimensionality of
the resolution of the cardiac mesh (thousands or millions). Direct estima-
tion of these HD model parameters from indirect measurements suffers
from two major issues. First, an increasing dimension of unknown pa-
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rameters increases the ill-posedness of the inverse problem given limited
measurement data, resulting in the un-identifiability of model parame-
ters. Second, the exploration of the HD parameter space in the presence
of a computationally expensive forward model becomes computationally
prohibitive.
• High computational cost: Significant progress has been made in the
multi-scale computational modeling of cardiac electrophysiology result-
ing in sophisticated simulation models with cell-to-organ level details.
However, with an increase in the model fidelity comes an increase in the
computational cost needed to evaluate these models. Since model pa-
rameters are indirectly related to the measurements through this com-
putationally expensive simulation, existing optimization and inference
methods will require repeated evaluation of this simulation model for
parameter personalization. Therefore, there is a challenge of high com-
putational cost associated with the need to repeatedly evaluate the sim-
ulation model.
• Sources of uncertainty: The personalization of model parameters is
subject to various sources of uncertainty. For example, model parame-
ters at the resolution of the cardiac mesh cannot be estimated directly
and they have to be approximated with a low-dimensional (LD) repre-
sentation [46, 68, 82, 83, 87]. Additionally, measurement data are noisy
and sparse. This uncertainty when propagated to the output of the
personalized model hinders its reliable application in clinical cardiology.
To rigorously understand and quantify the variability of the predictions
made by a personalized model, it is important to quantify the uncer-
tainty associated with the estimated model parameters. The estimated
uncertainty in the prediction provides a measure of the quality of the pre-
diction which is useful in determining whether the prediction is within
an acceptable limit. Additionally, the estimated uncertainty can pro-
vide various other valuable knowledge to the clinicians or the scientists,
for example, the non-identifiability of certain tissue properties, the cor-
relation between various tissue properties, and the uncertain modeling
elements. This knowledge can be useful in determining what additional
data needs to be gathered to improve the model’s reliability.
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1.2 Objectives and Contributions
Personalized cardiac models have found extensive use in patient-specific treat-
ment and therapy planning, the design and experimentation of medical de-
vices, and the study of disease progression [74]. One current challenge with
personalized models in these applications is that there are various free param-
eters related to the physiology (e.g., tissue properties, tissue distribution, etc)
or geometry (e.g., fiber directions, segmentation threshold, etc) that need to
be estimated from external measurements [44, 65, 74]. The estimation of pa-
rameters from noisy measurements can introduce uncertainty in the estimated
parameter values. Another important challenge is that these models employ
various implicit and explicit assumptions adding stochasticity to the model’s
output. Given the various sources of input variabilities, a point-estimate of
the model’s parameters is not sufficient for its reliable use in clinical and scien-
tific study. First, it is important to quantify the quality and confidence on the
predicted values to allow informed-decision making. Second, it is important to
understand various factors that are contributing to the variations in model’s
output to allow clinicians and scientists to either control these factors by so-
liciting additional measurements or to simply take into account these factors
when making decisions. In this context, the main objective of this dissertation
is to provide novel computational methods for uncertainty quantification and
parameter estimation in cardiac models.
The driving application here is the estimation of electrophysiological model
parameters using non-invasive ECG data and the quantification of uncertainty
in these model parameters. Because the measurements are indirectly related to
the model parameters through a non-linear physiological model, in addition
to the challenge of uncertainty, this application also presents a challenge of
solving an ill-posed inverse problem with high-dimensional (HD) unknowns
as described in Section 1.1. To handle the above challenges in personalized
modeling, this dissertation presents following major contributions:
• Bayesian Active Surrogate Modeling: Model personalization re-
quires the handing of an objective function or a posterior probability
density function that contains the complex and computationally expen-
sive simulation model. Our central idea to enable an accurate model
personalization within feasible computation is to learn an approxima-
tion (surrogate) of this computationally expensive target function and
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use it to guide the exploration of the parameter space during optimiza-
tion or inference. In this thesis, we introduce the concept of Bayesian
active learning for surrogate learning. In particular, a set of training
data points are sequentially and actively selected to learn an accurate
and efficient surrogate model of the target function. This surrogate is
then used for either accelerated optimization or inference.
• Active surrogate modeling in HD parameter space: Surrogate
modeling in HD space is difficult because the number of samples nec-
essary to ensure an accurate surrogate is exponential in the number of
dimensions. To enable surrogate modeling of an expensive target func-
tion defined over a HD space, we present two different approaches. First,
we present a geometry-based approach that learns a surrogate of the ob-
jective function progressively over gradually increasing dimensions of the
parameter space as defined by the multi-scale hierarchy of the cardiac
anatomy and further refined by a spatially-adaptive decision criterion.
Second, we present a data-driven approach that embeds the learning of
the surrogate model into a low-dimensional (LD) generative space of tis-
sue properties that is obtained by learning a generative model from the
LD latent space to the HD space of tissue properties.
• Surrogate accelerated Metropolis-Hastings (MH) Sampling: The
surrogate of a computationally expensive objective function can be used
to facilitate a sample efficient optimization. In this thesis, we extend this
idea to probabilistic estimation. In specific, we present a novel approach
to incorporate the surrogate model of the target probability distribution
function into the proposal distribution of the Metropolis-Hastings (MH)
sampling that will enable sampling with a reduced computation cost and
a higher acceptance rate.
1.3 Outline
This dissertation is organized as follows. Chapter 2 reviews the background
and related works on cardiac model personalization and Bayesian active sur-
rogate learning. Chapter 3 presents a spatially adaptive multi-scale surrogate-
based optimization to enable the estimation of HD model parameters [17,22].
Chapter 4 presents a HD Bayesian active optimization that is enabled through
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an embedded generative model [19, 20]. Chapter 5 presents a novel approach
to encode the anatomical knowledge into a generative model during parameter
estimation [21]. By incorporating the anatomical knowledge into the genera-
tive model, the approach presented in this chapter bridges the gap between
the geometry-based approach presented in Chapter 3 and the data-driven ap-
proach presented in Chapter 4. Chapter 6 details how a surrogate of the
probability density function learned with Bayesian active learning can be in-
corporated to accelerate MH sampling [18, 23]. Finally, Chapter 7 provides




2.1 Models of Cardiac Electrophysiology
The heart is an electro-mechanically coupled organ whose function is to pump
blood through the blood vessels to regulate the flow of oxygen, nutrients, and
waste products in the body. The rhythmic contraction and expansion of the
heart muscles for blood flow is controlled by the electrical function of the
heart. Specifically a node in the upper left atrium called sinoatrial node first
releases an electrical signal that will induce a pattern of electrical propagation
throughout the heart muscles. Any abnormality in the electrical property of
heart tissues can result in an abnormal pattern of electric propagation which,
in turn, might result in a lethal breakdown of the mechanical function of the
heart.
A 3D computational model of the cardiac electrophysiology can be ob-
tained by integrating the equations describing a cell scale cardiac electrophysi-
ology model onto a 3D anatomical model of the ventricles. To personalize these
3D cardiac electrophysiology models, the measurement data from patients is
utilized. In the following sections, we introduce the anatomical modeling of
the heart and the torso, cardiac electrophysiology model, and measurement
model in brief. For more detail, we refer the readers to [13,77].
7
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Figure 2.1: A pipeline showing patient-specific anatomy generation.
2.1.1 Anatomical Model
The anatomical model of a patient-specific heart and torso can be obtained
from the Computed Tomography (CT) scan images. A CT scan produces a set
of images that correspond to slices of the body along the torso. As outlined
in Fig. 2.1, a 3D bi-ventricular anatomical model is built from CT images by
taking the following steps. First, a set of images along the cross-section of the
ventricles (parasternal short axis) from the apex to the base of the heart is
extracted. On these images, the epicardium, left endocardium, and right endo-
cardium are segmented using an in-house semi-automatic routine. The binary
images thus obtained are then utilized to obtain a triangular mesh. A tetra-
hedral mesh is generated from the triangular mesh by utilizing the iso2mesh
package [27]. Finally, on the tetrahedral mesh a cloud of unstructured points
(meshfree nodes) are added to represent the 3D myocardial volume. The fiber
structures on the meshfree nodes are mapped from the standard ventricular fi-
brous structure mathematical model established in the literature as described
in [75,77].
The generation of the torso anatomy follows the same line as the generation
of the ventricles anatomy. Specifically first the torso is segmented on the
CT scan images using an in-house semi-automatic routine. These segmented
binary images are then used to built a triangular mesh of the torso.
2.1.2 Electrophysiology Model
The cardiac electrophysiology can be simulated in a patient-specific anatomical
model by integrating a cell scale model to tissue and organ scale [13, 14]. We
describe the cell-scale electrophysiology models and how they are integrated
to the organ scale in this section.
The electrical activity in the cardiac muscle cells occurs due the flow of
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different ions through ion channels and transporters in the cell membrane.
The resulting membrane current is known as Transmembrane potential or
action potential. Over the past few decades, a wide range of mathematical
models of cardiac electrophysiology varying in the level of detail and com-
plexity have been developed [13, 14]. These models can be broadly classified
into three types: biophysical, Eikonal, and phenomenological. Biophysical
models capture the microscopic level ionic interactions within the cardiac cell
and through the cell membrane. These models are biophysically detailed and
contain a large number of parameters to describe the function of different ion
channel, pump, and exchanger. The Eikonal models, on the other hand, focus
only on the propagation of the electrical wave-front and cannot accurately
describe the action potential. Phenomenological models offer a level of detail
that lies in between these two types of models. They capture the key macro-
scopic dynamical properties such as the inward and outward current. Because
these models have a small number of parameter and a faster execution time
compared to the biophysical models, they offer a practical balance between
model plausibility and computational feasibility for personalization of model
parameters [14]. Therefore, these models have found widespread use in model
personalization [32,49,52,63,68].
In this dissertation, we consider local parameter estimation for the two-
variable phenomenological Aliev-Panfilov (AP) model [2]:
∂u
∂t
= ∇(D∇u)− cu(u− θ)(u− 1)− uv,
∂v
∂t
= e(u, v)(−v − cu(u− θ − 1)).
(2.1)
where u is the normalized transmembrane action potential, v is the recovery
current, and e = e0 + (e1v)/(u + e2) controls the coupling between u and
v. Parameter D is the diffusion tensor that describes conductivity anisotropy
and is determined by the local fiber structure: the ratio of conductivities in
the longitudinal and transverse fiber directions is set to 4 : 1 according to
literature [29, 75]. Parameter c controls the repolarization and θ controls the
excitability of the cell.
To select the parameter to be estimated in the AP model, we conduct a
one-factor-at-a-time sensitivity analysis of the AP model with baseline values
of the parameters as documented in the literature [2]: θ = 0.15, c = 8, e0 =
0.002, e1 = 0.2, and e2 = 0.3. The shaded blue region in Fig. 2.2 shows the
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Figure 2.2: Result of one-factor-at-a-time sensitivity analysis of the AP model. Mean
(solid black) and standard deviation (std) (shaded blue) throughout the action po-
tential duration resulting from the variation in each model parameter.
standard deviation of u throughout the action potential duration resulting
from the variations in each model parameter. As shown, the average of these
standard deviations is the highest as a result from the variations in parameter
θ (tissue excitability). Furthermore, tissue excitability is documented to be
closely associated with the ischemic severity of the myocardial tissue [14,64,77].
Therefore, in this dissertation, we will consider the estimation of parameter
θ of the AP model. The physiological bounds on the value of parameter θ
is [0, 0.5] in which θ ∼ 0.15 represents normal excitability and an increase in
the value represents an increase in the severity of tissue infarct until θ ∼ 0.5
represents necrotic tissue. For the rest of the parameters, their values are fixed
to standard values as specified above.
The meshfree method is utilized to spatially discretize the AP model on
the patient-specific 3D bi-ventricular model and generate Transmembrane po-
tential activity model [77].
2.1.3 Electrocardiography Model
Generally in clinical cardiology, there are two ways to measure cardiac electro-
physiology: 1) invasive methods such as a point-to-point catheter mapping on
the heart surface [61,68], and 2) non-invasive method such as recording poten-
tials on the body surface also known as electrocardiogram (ECG) [59, 77, 84].
In the following section, we briefly describe the major measurement models
used in this study.
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Measurement Model
The transmembrane potential u(θ) can be, in general, observed by two means.
First, it generates extracellular potential Yb in the thorax following the quasi-
static approximation of the electromagnetic theory [57]. This relationship can
be modeled by a Poisson’s equation within the heart and a set of Laplace’s
equations, one for each organ, external to the heart and within the body
torso. Given a discrete subject-specific mesh of the thorax, these equations are
solved as described in [79] to obtain a linear relationship between extracellular
potential Yb and transmembrane potential u(θ) through a subject-specific
transfer matrix Hb:
Yb = Hbu(θ). (2.2)
When measured on the heart surface, Yb is known as electrograms; when
measured at the body surface, Yb is known as ECG—the latter is non-invasively
available in practice but more challenging for parameter estimation, because
it represents a more remote and sparse observation of u(θ). This is the main
measurement model that we utilize for parameter estimation.
Alternatively, transmembrane potential u(θ) may be locally recorded on
the epicardium through optical mapping [62,78]:
Ye = Heu(θ), (2.3)
where Ye represents coarsely distributed subset of transmembrane potential
u(θ) measured at local regions of the epicardium, indexed by a sparse binary
matrix He. This is a second measurement model that we will use in some of
the parameter estimation experiments. For clarity, throughout the remainder
of this dissertation, we use Y to denote either Ye or Yb, and H to denote
either He or Hb.
Electrocardiography
Electrocardiography is a non-invasive method that involves measuring poten-
tials on various locations on the body surface over time. A schematic of a nor-
mal ECG signal is shown in Fig. 2.3. It consists of following major segments:
P wave, PR segment, QRS complex, ST segment, and T wave. Different seg-
ment of the ECG corresponds to different stages of electrical activity in the
heart which can be utilized to trace specific abnormal electrical function of
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Figure 2.3: A schematic diagram of normal sinus rhythm for a human heart as seen
on ECG [77].
the heart. In particular, the P wave corresponds to atrial depolarization, PR
segment corresponds to the propagation of the activation through the Atri-
oventricular node and the Purkinjie fiber, QRS complex corresponds to the
depolarization of the ventricles, ST segment corresponds to the stage when all
myocytes remain at the plateau and all regions in the ventricles are at depo-
larized state, and T wave corresponds to the re-polarization of the ventricles.
Classical ECG consisted of a recording system consisting of three electrodes
positioned on the left arm, right arm, and left leg of the patient from which
three limb voltages VI , VII , and VIII were calculated [26]. An extension and
the most commonly used 12-lead ECG standard consists of six additional
electrodes that provide six additional measurements V1−6.
Often the standard 12-lead ECG is not adequate for clinical diagnosis
and treatment planning of heart diseases and a more elaborate Body Surface
Potential Map (BSPM) is utilized. A BSPM consists of potentials recorded on
the body surface with tens to hundreds of electrodes [51]. In this dissertation,
we primarily use the 120-lead BSPM (referred to as 120-lead ECG throughout
the remainder of this dissertation).
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2.2 Personalization of Model Parameters
2.2.1 Parameter Estimation of Complex Physiological Models
Cardiac tissue properties typically cannot be directly measured but needs to
be estimated from sparse and indirect measurements. The estimation of car-
diac model parameters, therefore, consists of an ill-posed inverse problem in
which the forward model contains a non-linear and computationally expensive
simulation model. This forward model when used in the objective function for
a deterministic parameter estimation or in the probablity distribution func-
tion for a probabilistic parameter estimation results in a challenge of handling
an intractable function for parameter estimation. In particular, this target
function of interest does not have a closed form expression, its derivatives are
difficult to obtain, its convexity property is unknown, and it is computationally
expensive to evaluate.
In the past few decades, significant progress has been made in deterministic
approaches that handle complex objective function containing the simulation
model in parameter estimation. In particular, various methods of derivative-
free optimization were presented to handle the analytically-intractable objec-
tive function, such as the use of the subplex method [83], Bound Optimization
BY Quadratic Approximation (BOBYQA) [82], and New Unconstrained Op-
timization Algorithm (NEWUOA) [68]. More recently, effective methods of
multi-scale derivative-free optimization were developed [10,11]. Essentially, all
these methods involve a non-intrusive, repeated evaluation of the physiologi-
cal model. Hence, the computational cost in model personalization is mostly
dependent on the number of evaluations of the objective function required by
these methods.
Deterministic approaches focus on obtaining a single value of the model
parameters that best fits the available data (under given optimization crite-
ria); they do not provide an uncertainty measure associated with the estimated
patient-specific parameter values. Limited works have been reported on prob-
abilistic approaches to estimate the distribution of patient-specific parameters
of a cardiac model. Recent studies handle the complex posterior probablity
density function (pdf) of model parameters by building an efficient surrogate
of the simulation model using methods such as kriging [67] and polynomial
chaos [44]. This approximate but efficient simulation is then used to replace
the exact simulation in the posterior pdf for a substantially faster Markov
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Chain Monte Carlo (MCMC) sampling of the posterior pdf [44,67].
2.2.2 High-dimensional Parameter Estimation
While various deterministic and probabilistic approaches to estimate model
parameters have been proposed over the past few decades, none of the existing
methods can be directly applied to estimate the high-dimensional (HD) model
parameters corresponding to the spatially-varying tissue properties. This is
because the increased dimension of unknowns: 1) increases the ill-posedness of
the problem, where estimation of parameters at the resolution of the discrete
cardiac mesh is likely to be unidentifiable given limited indirect measurements,
and 2) leads to an exponential increase in the number of model evaluations,
where each model evaluation itself is computationally intensive.
As a result, most previous works resort to the estimation of parameters
at a reduced spatial dimension. Many works focus on the estimation of a
global parameter [49,53] by assuming uniform tissue property throughout the
myocardium. Although such estimation allows a fast model calibration, it
does not capture the locally varying tissue properties. Another approach is
to reduce the dimension of the unknowns by partitioning the cardiac mesh
into pre-defined segments and to assume uniform parameter value within each
segment. This reduces the spatial field of tissue properties to a low-resolution
representation (in the range of 3-26 segments) [32, 44, 46, 68, 82, 83, 87]. As a
result of this drastically decreased resolution, the solution has a limited ability
to reflect different levels of tissue heterogeneity, or the existence of local abnor-
mal tissue with various sizes and distributions. Additionally, as the number
of pre-defined segments increases, a good initialization is shown to become
critical to the accuracy of parameter estimation [83]. This unfortunately re-
lies on the availability of measurement data that can reveal diseased regions a
priori. Therefore, a critical gap remains in personalized modeling between
the needs for a high resolution estimation of spatially-varying parameters and
the difficulty to accommodate such high dimensionality by existing estimation
approaches.
2.2.3 Bayesian Active Approximation of Expensive Functions
In domains such as the computational astrophysics [15] and geothermal re-
search [16] one often needs to estimate a probability density of the simulation
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model parameters that neither has a tractable analytical form nor is cheap to
evaluate. Similarly, in applications like optimal drug design [80] and optimal
user preferences selection [1] the objective function to be optimized does not
have a closed-form expression and is costly to evaluate. In these applications,
MCMC sampling methods that consist of repeated sampling and evaluation of
the unknown function for learning its approximation are used [39]. However,
MCMC methods are not designed to actively choose sample points on which
to evaluate the expensive function. Therefore, these function approximation
technique require a large number of samples making them computationally
expensive.
On the other hand, recent Bayesian active learning methods are designed
to actively select sample points with an aim to achieve an accurate result with
as few evaluations of the expensive function as possible [7, 39, 40]. Therefore,
Bayesian active learning methods such as Bayesian optimization [7, 38] and
Bayesian quadrature [41,54] have been used in various tasks that require mod-
eling an intractable and expensive unknown function. These class of methods
have two major components. First, a surrogate model of the expensive func-
tion that is learned from the samples collected so far. Second, an acquisition
or a utility function that uses the surrogate of the expensive function in guid-
ing the selection of future samples. The acquisition function has a capability
to balance between exploration of the support of the unknown function and
exploitation of the important regions in the support.
For surrogate modeling a Gaussian process (GP) is often utilized [?, 7,
46, 47, 70]. A GP is a random process with an infinite number of random
variables, any finite subset of which has a joint Gaussian distribution [60]. It
thus provides a distribution over functions f(·) ∼ GP(µ(·), κ(·, ·)) that is fully
characterized by a mean function µ(·) and a covariance function κ(·, ·) [60].
GP has been successfully utilized in many non-linear Bayesian regression tasks.
In a typical regression setting, given a set of training input-output pairs Θ =
[θ1, θ2, ...θn]
T and G = [g1, g2, ...gn]T, one is interested in making a prediction
g∗ for any given θ∗. In standard regression with GP, this is achieved by
estimating an unobserved latent function that is responsible for generating g
from θ: g = f(θ)+N (0, ς2). A GP is used to define prior distribution over the
latent function f(·) ∼ GP(0, κ(·, ·)). Then, using the properties of Gaussian
distribution, the predictive mean µ(θ∗) and variance σ2(θ∗) can be obtained




σ2(θ∗) = κ(θ∗, θ∗)− kT (K+ ς2I)−1k,
(2.4)
where k = [κ(θ∗, θ1), κ(θ∗, θ2), · · ·κ(θ∗, θn)]T and K is the positive definite
co-variance matrix with Ki,j = κ(θi, θj). In active learning setting, these
training input-output pairs are gradually collected by using an acquisition
function. The acquisition function takes the predictive GP mean and variance
for sample selection and trades off between a large GP posterior mean given the
current GP belief of the unknown function (i.e., exploitation) and a large GP
posterior variance to reduce the uncertainty of the GP belief of the unknown
function (i.e., exploration).
While Bayesian active approximation approaches are widely used for ap-
proximating and optimizing expensive functions, they do not work well when
the function is defined over a HD (dimension > 15) space [39,47,70]. This is be-
cause the number of training data required for nonparametric regression with
GP grows exponentially with the dimension on with the function is defined.
In addition, the active sample point selection involves global optimization of
a HD acquisition function which is an inherently difficult [39,47,70].
This thesis builds-upon Bayesian active approximation of expensive func-
tions defined over a HD space for both deterministic and probabilistic estima-
tion. In the following chapters, we describe various methods for HD Bayesian
active surrogate modeling and approaches to accommodate these surrogate




The estimation of spatially varying parameter values of a 3D cardiac EP model
is important for revealing abnormal tissues with altered material properties
and for building patient-specific models. As explained in Chapter 2, to re-
duce the dimension of unknown parameters existing works in local parameter
estimation typically represent the heart with a small number of pre-defined
segments. Such low-resolution approaches have limited ability to estimate
tissues with varying sizes, locations, and distributions.
In this chapter, we present a novel framework that goes beyond a uniform
low-resolution approach and achieves a higher resolution estimation of tissue
properties represented by spatially non-uniform resolution. This is achieved
by two central elements: a multi-scale coarse-to-fine surrogate-based optimiza-
tion and a spatially adaptive decision criterion that retains lower resolution
in homogeneous tissue regions and allows higher resolution in heterogeneous
tissue regions. The surrogate model-based optimization allows to incorporate
and approximate complex objective function in optimization and the spatially-
adaptive multi-scale approach allows to handle a high-dimensional unknown.
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3.1 Introduction
i. A surrogate-based multi-scale optimization framework that progressively
optimizes from lower resolution to higher resolution, where a lower reso-
lution solution is used to facilitate the higher resolution optimization.
ii. An adaptive decision criterion that allocates higher resolution to regions
with heterogeneous tissue properties, allowing a higher resolution param-
eter estimation without using a large number of unknowns.
iii. Development of the adaptive decision criterion with two optimization
methods: 1) Gaussian process (GP) surrogate based optimization (GPO) [7],
and 2) Bound Optimization BY Quadratic Approximation (BOBYQA) [58];
and comparison with standard BOBYQA carried out on a pre-defined di-
vision of cardiac mesh into 26 segments.
iv. Evaluation of the presented framework in the estimation of local tissue
excitability in a 3D cardiac electrophysiological (EP) model, using several
measurement data including 120-lead ECG, 12-lead ECG, and epicardial
action potentials.
We test the performance of the framework presented in this chapter on
three categories of experiments. First, on synthetic experiments, we evaluate
the presented method in estimating local tissue excitability: 1) in the presence
of infarcted tissues of varying sizes and locations, and 2) using 120-lead ECG
vs. using 12-lead ECG. Second, we apply the presented method to estimate
local tissue excitability on seven patients with prior myocardial infarction,
where a subset of epicardial potentials simulated from a high-resolution ionic
electrophysiological model blinded to the parameter estimation framework is
used as measurement data. Finally, we conduct two pilot studies on patients
who underwent catheter ablation of ventricular tachycardia due to prior tissue
infarction by using non-invasive 120-lead ECG as measurement data. Results
show that the presented framework is able to characterize local abnormal
infarct tissues without using any knowledge of the abnormal tissue derived
from other data modalities.
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3.2 Spatially-Adaptive Multi-Scale Optimization
Estimation of the three dimensionally distributed tissue excitability in a car-





with bounds constraint: Ω = {θ ∈ Rm|lb ≤ θ ≤ ub}. The objective function
J could be any measure of similarity between the model output Φ and the
measured ECG Y, such as a measure of the similarity in signal magnitude by
squared error, or a measure of the similarity in signal morphology by corre-
lation coefficient. Because the measurement ECG data tend to be noisy and
there is often a scale difference between the measured and simulated data,






j=1 (yij − ȳi)(Φij − Φ̄i)







where l is the number of body surface leads, t is the number of discrete time
samples, and Φ̄i and ȳi are respectively the mean of simulated and measured
ECG on the ith body surface lead. The correlation coefficient takes value in
the range [−1, 1] and the value of the squared error depends on the unit of
measurement data. Parameter λ is empirically adjusted using the knowledge
of the two.
The direct estimation of θ involves a high-dimensional (HD) optimization
that is infeasible due to high ill-posedness and prohibitively large computa-
tion. To maximize the resolution of local parameter estimation using a lim-
ited dimensionality of unknowns, we present a spatially-adaptive multi-scale
scheme that can be used in conjunction with any optimization method. This
framework consists of three key components: 1) a multi-scale hierarchical rep-
resentation of the spatial domain, 2) a coarse-to-fine optimization, and 3) a
criterion for adaptive spatial resolution adjustment that favors higher resolu-
tion in heterogeneous regions. The workflow chart in Fig. 3.1 shows how each
of the key components work together in the presented framework. Given a
discrete cardiac mesh, we first construct the multi-scale representation of the
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Figure 3.1: A work-flow diagram of the spatially adaptive multi-scale optimization
framework.
Figure 3.2: Multi-Scale hierarchy with 20, 15, 10, 5, and 1 final clusters (left to
right); color is repeated for unconnected clusters.
spatial domain. Parameter estimation is then carried out as an iterative pro-
cedure of coarse-to-fine optimization with an adaptive adjustment of spatial
resolution, until further refinement does not produce major improvement in
the global optimum. Individual components of the framework are detailed in
the following sections.
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3.2.1 Multi-Scale Hierarchy
To facilitate a coarse-to-fine optimization, a multi-scale representation of the
cardiac mesh is needed. By exploiting the spatial smoothness of tissue prop-
erties (i.e., neighboring tissues have similar material properties), we adopt
a bottom-up agglomerative hierarchical clustering [34]. It begins with every
node in the cardiac mesh as separate clusters. As one moves up the hierarchy,
a pair of the closest clusters is merged until all the nodes belong to a single
cluster. The distance between two clusters is measured by the average of the
pairwise Euclidean distance between every node in the two clusters. Fig. 3.2
shows the clusters of this multi-scale hierarchy at several scales, illustrating
(from left to right) how two clusters at a lower scale is merged into a cluster at
a higher scale. The finest level in the multi-scale hierarchy corresponds to the
beginning stage of the clustering. At this stage parameter estimation would
correspond to a direct HD local parameter estimation at the resolution of the
cardiac mesh. The coarsest level in the multi-scale hierarchy corresponds to
the end stage of the clustering where every nodes belong to the same cluster.
At this stage, parameter estimation would correspond to a global parameter
estimation.
3.2.2 Coarse-to-Fine Optimization
In optimizing a complex objective function, a coarse-to-fine optimization may:
1) facilitate faster convergence by exploiting coarser-scale information in finer-
scale optimization, and 2) decrease the risk of being stuck in a bad local
minimum by optimizing a cascade of increasingly complex objective functions
over a gradually increasing resolution.
The optimization starts from the coarsest scale of the multi-scale hierar-
chy. It then progressively optimizes the parameters at a higher resolution
that is determined by the adaptive spatial resolution adjustment criterion
(Section 3.2.3). For clarity, in this study, we represent the change in reso-
lution during the coarse-to-fine optimizations using a tree, in which the leaf
nodes represent the clusters in the present resolution. At the kth iteration, we
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In the presented framework, any optimization method that can handle the
objective function (3.2) can be used. As an example, below we present the
presented framework with GPO [70]. The use of the presented framework with
BOBYQA [58] follows the same line and will be discussed in the experiment
section.
A GP is first used to approximate the objective function (3.3). The GP
assumes a smoothness property of the objective function which is mainly deter-
mined by its co-variance function. Because the most commonly used squared
exponential kernel is known to enforce a large smoothness property, we take



















where d = ||θ(k)1 −θ
(k)
2 ||, and γ and α are kernel parameters. Because no prior
knowledge about the objective function (3.3) is available, we use a zero mean
function for simplicity.
A typical surrogate based optimization consists of two major ingredients:
1) using the current surrogate of the objective function, find out points in the
solution space that can improve the approximation of the objective function
well especially in the region of global maximum, and 2) evaluate the objective
function at the point determined in the previous step and update the sur-
rogate. Because the initial knowledge of the GP plays an important role in
determining how fast a good GP can be obtained in the subsequent updates,
here we introduce an additional step to initialize the GP using the coarser-scale
optimum. Below we describe each of these major steps:
Initialize Using the Coarser-Scale Optimum: Depending on the optimiza-
tion method used, different strategies can be used. If the optimization starts
with a single point, such as the BOBYQA used here, the lower resolution opti-
mum can be used as initialization. If the optimization can start with multiple
points, such as the GPO used here, a set of higher resolution points derived
from the lower resolution optimum can be used. For two sibling leaf nodes
obtained by recent refinement, a set of two values whose average equals to the
value on the parent node (lower resolution optimum) are generated. This is
done by first uniformly sampling a set of values from the parameter bound [lb,
ub] for one of the leaf nodes. Then, corresponding set of values for the second
leaf node are generated by subtracting previous samples from twice the value
on the parent node. For leaf nodes that did not undergo resolution change,
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their parameter values are equal to their current optimum. These points are
used to obtain an initial GP surrogate.
Determine the Next Query Point: In the context of optimization, a good
surrogate should both approximate the objective function well globally, and
have higher accuracy in the region of global maximum. For the former, the
query point is determined to explore the solution space where the predictive
uncertainty σ(θ(k)) of the current GP is high. For the latter, the query point is
determined to exploit the current GP at the solution space where the predictive
mean µ(θ(k)) is high. Overall, this nth query point is obtained by maximizing







where the parameter β = 2 log(π2n2/6η), η ∈ (0, 1) balances between ex-
ploitation and exploration. The predictive mean and uncertainty in (3.4) is
evaluated by using the Sherman-Morrison-Woodbury formula [60]:
µ(θ(k)n ) = k
T (K+ ς2I)−1J1:n−1, (3.5)





















and K is the posi-
tive definite co-variance matrix Ki,j = κ(θ(k)i , θ
(k)
j ). A small noise ς is added
for numerical stability during matrix inversion.
Update the GP: Once a new query point is obtained, the objective function
(3.3) is evaluated at this point. GP is updated at the new point-objective


















This provides an updated GP. In this study, we set the values of the ker-
nel hyperparameters empirically. These steps are run in iteration until the
query points do not change significantly over several iterations. In this way,
a GP surrogate of the objective function along with the optimum at a given
resolution is obtained.
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3.2.3 Adaptive Spatial Resolution Adjustment
If coarse-to-fine optimization is done on the full multi-scale hierarchy, the
number of unknowns will again quickly become too high in dimension to be
effectively optimized. To overcome this, we aim for a non-uniform resolution
with higher resolution in heterogeneous regions and lower resolution in homo-
geneous regions. To achieve this, instead of refinement of all the leaf nodes
after optimization at each scale, we selectively refine the leaf nodes that are
heterogeneous and coarsen those that are homogeneous.
To identify the clusters that are heterogeneous versus homogeneous in
tissue properties, we propose a greedy criterion based on gain in the global
optimum. Intuitively, if a cluster is homogeneous, its refinement is expected
to yield children clusters with similar parameter values; as a result, there will
be a minimal gain in the objective function in representing this region with
higher resolution. The contrary is true for heterogeneous clusters.








that share the common
parent node θ̂(k−1)p , we evaluate the gain resulting from the refinement as
the change in the objective function value on θ̂(k) (current optimum) versus








with the value of their













is the parameter vector obtained by




p in the current optimum θ̂(k). For leaf
nodes that do not have a sibling due to previous coarsening, no resolution
change has occurred but their value may have changed as a result of resolution-
change elsewhere. For such nodes θ̂(k)q , the gain r(k)q equals the change in the
objective function due to the change in θ̂(k)q during the coarsening and after
the optimization.
Based on r(k)i , two actions are taken. For the leaf node or the pair of leaf
nodes that has the maximum gain r(k)i , we hypothesize that they represent
highly heterogeneous regions and allow a higher resolution representation (i.e.,
refinement). For the pair of leaf nodes that bring negligible or negative gain
(r(k)i < ϵ), we assume that the refinement suggested in the previous scale is not
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Figure 3.3: Schematics of 26 pre-defined ventricular segments for optimization with
uniform resolution.
beneficial and thus retract the refinement (i.e., coarsening). The refinement
and coarsening is done by using the multi-scale hierarchy (Section 3.2.1) as a
reference.
3.3 Evaluation on Synthetic Data
In synthetic experiments, we evaluate the performance of the presented frame-
work in combination with the GPO and the BOBYQA (termed as adaptive
GPO and adaptive BOBYQA respectively for the remainder of this chapter)
in the presence of infarcts of varying sizes and locations. We also compare
the presented framework with optimization using 26 pre-defined segments of
ventricles, with 17 segments on the left ventricle (LV) based on the Ameri-
can Heart Association (AHA) standard and 9 segments on the right ventricle
(RV) as shown in Fig. 3.3. Finally, we study the identifiability of local tissue
excitability with respect to: 1) the size of the infarct, and 2) the amount of
measurement data.
In total, we consider 35 synthetic cases with different settings of infarcts
on three realistic CT-derived human heart-torso geometrical models. We set
infarcts of sizes varying from 1% to 65% of the ventricles at different LV and
RV locations by using various combinations of the pre-defined segments, or
random locations when the size is smaller than one pre-defined segment. To
represent healthy and infarcted tissues, the parameter θ of the AP model (2.1)
is uniformly sampled from [0.149, 0.151] and [0.399, 0.501] respectively. For
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Figure 3.4: Synthetic experiments. Examples of the progression of the presented
spatially-adaptive multi-scale optimization. Left: true parameter settings vs. esti-
mation results improved over 3 successive stages of the optimization (red: infarcted
tissue, blue: healthy tissue). Right: the corresponding structure of the tree at each
stage. The value on each node of the tree represents the optimized parameter value
for that node.
each infarct case, the action potentials are first simulated using the AP model.
120-lead ECG is then generated using the forward model and corrupted with
20dB Gaussian noise. The admissible range of tissue excitability parameter for
the optimization is set to [0, 0.52]. To evaluate the accuracy of the estimated
local parameters, we use two metrics: 1) root mean squared error (RMSE)
= ||θ̂ − θ||2 between the true and estimated parameter values, and 2) dice
coefficient (DC) = 2|S1∩S2||S1|+|S2| , where S1 and S2 are the sets of nodes in the true
and estimated regions of the infarct; these regions are determined for each
infarct case by calculating a threshold value that minimizes the intra-region
variance [55] on the estimated parameter values. Both metrics are evaluated
at the resolution of the cardiac mesh.
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3.3.1 Performance Based on the Size and Location of the In-
farct
We first summarize the performance of the presented framework in the pres-
ence of infarcts of varying sizes using three representative examples. Fig. 3.4(a)
shows an example of estimation on a small infarct (3.6%). The tree shows that
once a homogeneous healthy region is found in stage 1, the optimization keeps
the entire region at a very low resolution and refines only along the hetero-
geneous region that contains the infarct. It continues narrowing down the
infarct with higher resolution, generating a narrow yet deep tree. The final
result shown in stage 3 of Fig. 3.4(a) is achieved with only a dimension of 10
unknowns. In comparison, if a uniform resolution is used, a dimension of 128
would be needed to achieve an estimation at the same resolution. Fig. 3.4(b)
shows another example with a medium sized infarct (28.7%). Since the in-
farct spans a larger number of clusters, it is not until stage 2 before the tree
can be split along one major branch. In addition, because both normal and
infarcted tissues are large enough to be represented by low-resolution homo-
geneous clusters, an overall lower resolution solution is obtained with a wider
yet shallower tree. While the presented method converges at a dimension of
7, a uniform resolution would require a dimension of 16 for an estimation at
similar resolution. Finally, Fig. 3.4(c) shows an example with a larger sized
infarct (62.4%). A larger sized infarct can be represented by big clusters at
low resolution and has a boundary that needs to be represented by a larger
number of smaller clusters. Therefore, until stage 2 the large homogeneous
regions (both normal and infarcted) are split into major clusters. In the fol-
lowing stages, the border region is split into multiple branches increasing the
resolution along the border yielding a wider tree in the first a few steps and
narrow branches in later stages. In this case, while the presented method con-
verges at a dimension of 13, a uniform resolution estimation would require a
dimension of 64.
Additional examples of the estimated tissue excitability for different in-
farcts are provided in Fig. 3.5. Fig. 3.6 summarizes the accuracy in estimation
of the presented adaptive BOBYQA (magenta bar) and adaptive GPO (blue
bar) with respect to the size and location of the infarct. Specifically as shown
in Fig. 3.6, while both the presented methods are in general able to identify
infarcted tissues at various locations and of various sizes, the accuracy in the
presence of septal infarcts show a noticeable decrease. As shown in an ex-
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Figure 3.5: Synthetic experiments. Examples of tissue excitability estimated using:
1) uniform BOBYQA, 2) adaptive BOBYQA, and 3) adaptive GPO in the presence
of infarcts of varying sizes and locations (red: infarcted tissue, blue: healthy tissue).
Infarct locations and sizes (in percentage ventricles covered) from top to bottom:
anterior (3.17%), inferior (9.84%), and septal (24.31%).
Figure 3.6: Synthetic experiments. Comparison of uniform BOBYQA, adaptive
BOBYQA, and adaptive GPO in terms of DC and RMSE based on 35 different
infarct cases of varying sizes and locations (bar: mean, line: standard deviation).
ample of septal infarct in Fig. 3.5(c), this drop in accuracy is associated with
the presence of false positives at the lateral ventricular walls. This implies
the existence of multiple parameter configurations that fit the measurement
data well. The challenge in dealing with septal infarcts is consistent with
that reported in literature [79]. Interestingly, in the presence of septal infarct,
adaptive GPO shows higher accuracy than the adaptive BOBYQA (Fig. 3.6).
This could be because adaptive GPO was able to avoid local minima owing to
the initialization with multiple points. The adaptive BOBYQA, however, in
general has higher efficiency, especially in the estimation of higher dimension
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Figure 3.7: Synthetic experiments. Comparison of the final dimensions of unknowns
obtained by using presented methods based on 35 infarct cases of various sizes (bar:
mean, line: standard deviation).
of unknowns. Because both presented methods show similar performance, in
the remaining sections of this paper, we consider performance analysis of the
presented framework using adaptive GPO only unless explicitly stated other-
wise.
3.3.2 Comparison with Optimization using Uniform Resolu-
tion
We compare the performance of the presented adaptive methods with the
state-of-the-art BOBYQA using 26 pre-defined segments (termed as uniform
BOBYQA for the remainder of this paper). We do not include comparison with
GPO using 26 pre-defined segments because it performs poorly for a dimension
higher than 20 both as reported in literature [70] and as observed in our
experiments. Experimental setup as described in Section 3.3 is used. Because
uniform BOBYQA is sensitive to initialization, each experiment case is run
twice using random initialization and the better result is picked for comparison.
The summary statistics of accuracy as shown in Fig. 3.6 demonstrates that
the presented adaptive methods are more robust to infarcts of various sizes
and locations. This improvement is statistically significant in both DC and
RMSE (paired-t tests on 35 synthetic experiments, p < 0.0025). In particular,
using uniform BOBYQA, it is difficult to estimate an infarct of size equal
to or less than a single segment. In comparison, the presented methods are
able to identify infarcts smaller than a single segment with a small number
of unknowns (10-14). Furthermore, as shown in Fig. 3.5, uniform BOBYQA
tends to show false-positives across multiple segments, failing to accurately
reveal the spatial distribution of the infarcted tissues.
The major computational cost in local parameter estimation comes from
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the repeated evaluation of the CPU-intensive simulation model. We com-
pare the computational cost of the presented adaptive methods and uniform
BOBYQA in terms of the computation time and the number of model evalua-
tions used. This is based on 35 synthetic experiments conducted on a computer
with Xeon E5 2.20GHZ processor and 128 GB RAM. In summary, uniform
BOBYQA takes on average 3.33±0.83hrs for convergence, while the presented
methods take on average 6.07±3.02hrs for convergence. Because, in the pre-
sented methods, the tree varies with varying infarct sizes leading to a signifi-
cant difference in the number of model evaluations, we compare the number
of model evaluations into two categories. For smaller and larger infarcts, the
trees are deeper involving multiple coarse-to-fine optimizations and an aver-
age of 10-12 final dimensions of unknowns (Fig. 3.7). Such cases in general
require a larger number of model evaluations. Our experiments show that
the presented methods take at most twice as many model evaluations. How-
ever, it should be noted that uniform BOBYQA for such cases as shown in
Fig 3.5 and 3.6 suffer from limited accuracy in estimation. For average sized
infarcts, the trees are shallower and end up with an average of 7-8 unknown
dimensions (Fig. 3.7), resulting in a fewer number of coarse-to-fine optimiza-
tions of a smaller number of unknowns. Compared to uniform BOBYQA,
the presented methods require a similar number of model evaluations. In the
presented methods, the adaptive spatial resolution adjustment step also neces-
sitates model evaluations. Supposing that at a stage there are 2n leaf nodes,
a minimum of n model evaluations (when all nodes have sibling) and a maxi-
mum of 2n model evaluations (when no nodes have sibling) are needed. At the
current stage where the number of leaf nodes are typically < 20, the number
of model evaluations needed for spatial resolution adjustment is insignificant
in comparison to that needed for optimization (at a range thousands).
3.3.3 Identifiability Based on the Size of the Infarct
To investigate the limit of the presented method in terms of the smallest size of
the infarct that can be identified, we conduct a set of experiments by gradually
decreasing the size of an infarct until a size that cannot be identified is found.
For such a size of infarct, six different experiments are repeated. In summary,
an infarct of size ≥ 3% can be estimated with good accuracy, ∼ 2% can be
identified with lower accuracy, and ∼ 1% cannot be identified. Fig. 3.8 shows
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Figure 3.8: Synthetic experiments. Left: tree narrows down along the infarct region
showing that the infarct is identified. Right: tree takes first a few steps along the
infarct region, but later splits along homogeneous healthy region showing that the
infarct is not identified.
two examples of estimation for infarcts of different sizes. For an infarct of size
3.6%, the tree progressively branches by allocating higher resolution along the
infarct and lower resolution along the homogeneous normal regions. However,
for an infarct of size 2.0%, the tree branches along the infarct only for first
a few steps (until H-3) and later branches along the homogeneous normal
tissue. This shows that no significant gain in objective function was obtained
by dividing the heterogeneous regions containing the infarct. Rather, the
gain in objective function by refining the homogeneous regions (fine tuning of
parameter values) is comparable to that by refining the heterogeneous region.
Hence, in this case the infarct was not observable given the current data and
the objective function used.
3.3.4 Identifiability Based on the Amount of Measurement
Data
We investigate the change in the performance of the presented method when
the amount of measurement data is decreased from 120-lead ECG to 12-lead
ECG on 35 synthetic experiments. Experimental setup as described in Sec-
tion 3.3 is used. In addition, 12-lead ECG is extracted from the simulated
and noisy 120-lead ECG. As summarized in Fig. 3.9, an overall decrease in
the accuracy across both metrics is observed. This is mainly due to larger
false positive regions and sometimes non-unique solutions. The accuracy in
estimation when infarcts are located at inferior LV and RV regions shows
major decline. Fig 3.10 shows an example of estimation when an infarct is
present in the inferior LV. Using 120-lead ECG, the presented method is able
to progressively narrow down to the infarct region. Using 12-lead ECG, all
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Figure 3.9: Synthetic experiments. Performance of the presented method using 12-
lead ECG in comparison to that using 120-lead ECG in terms of DC and RMSE.
Comparison is based on 35 different infarct cases of varying sizes and locations (bar:
mean, line: standard deviation).
Figure 3.10: Synthetic experiments. Estimation using 120-lead ECG shows good
accuracy with splits along the infarct region, whereas using 12-lead ECG is unable to
identify the infarct.
the nodes in the tree take the value of 0.15 showing that the infarct is not
identified. The drop in accuracy, especially in the RV and inferior LV, could
be explained by the limited presence of leads in the inferior and RV side in
the 12-lead ECG set.
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3.4 Evaluation on a Blinded EP Model and In-vivo
MRI Scar
We next test the performance of the presented method in estimating tissue
property of 3D myocardial infarct delineated from high resolution in-vivo mag-
netic resonance (MR) images. Compared to the settings in synthetic exper-
iments, these MRI-derived 3D infarct has the following characteristics that
can be expected to increase the difficulty of local parameter estimation: 1)
heterogeneous tissues due to the presence of both dense scar core and gray
zone, 2) the presence of a single or multiple scars with complex spatial distri-
bution and irregular boundary, and 3) the presence of both transmural and
non-transmural scars. Due to the lack of in-vivo electrical mapping data, here
measurement data for parameter estimation are generated by a high resolu-
tion (average resolution of 350 µm), multi-scale (sub-cellular to organ scale)
in-silico ionic electrophysiological model on the MRI-derived patient-specific
ventricular models as detailed in [4]. Data are extracted from 300-400 epi-
cardial sites, temporarily down-sampled to a 5ms resolution, and corrupted
with 20dB Gaussian noise. Note that although no in-vivo electrical data were
available for parameter estimation, the experiments are designed to mimic a
real-data scenario because: 1) the 3D electrophysiological model used to gen-
erate the measurement data is known to be capable of generating high-fidelity
electrophysiological simulation of patient-specific heart [4], 2) this model is un-
known to the framework of parameter estimation and thus no “inverse crime”
is involved, and 3) only a subset of epicardial surface data corrupted with noise
is used as measurement data. Fig. 3.11 shows the local tissue excitability es-
timated using the presented method on 7 cases. Based on the fundamental
assumption of the presented method (higher resolution in heterogeneous re-
gions), we expect that its performance will be closely tied to the underlying
heterogeneity of the tissue property. Therefore, we analyze the performance
of the presented method with respect to the following two factors that affect
the heterogeneity of the scar:
1) Scar Transmurality: Because scar non-transmurality increases tissue
heterogeneity across the myocardial wall, it is expected that the estimation
accuracy in the presence of dense transmural scars would be higher than that
in the presence of non-transmural scars. Specifically cases 4-7 have some dense
transmural scars surrounded by gray zone. In these cases, the location of the
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Figure 3.11: Results of local parameter estimation using the presented method,
where measurement data is generated from epicardial potentials simulated by a multi-
scale ionic electrophysiological model blinded to the presented estimation method.
Infarct from 3D-MRI is used as the ground-truth.
dense transmural scar is accurately identified with the estimated parameter
value close to the documented parameter value for infarct core (i.e., 0.5) [14].
In comparison, the non-transmural scars in case 1 anterior-septal region and
case 4 apical region are missed. The tissue property for the non-transmural
scar in case 3 apical region and case 5 inferior region, although identified, are
not accurately estimated. Overall, in the presence of non-transmural scars,
the estimation either misses the scar, or produces regions of abnormal tissues
larger than the scar with parameter value in between the values for healthy
and infarct core.
2) Dense vs. Gray Zone: The presence of gray zone is also expected to
increase the difficulty in parameter estimation. For example, tissue property
in dense scar in cases 4, 6 apical region and case 2 anterior region are correctly
estimated, whereas the gray zone in case 1 septal region is missed. Addition-
ally, as shown in Fig. 3.11 case 5 view 1, the presence of gray zone within the
dense scar decreases the estimation accuracy. In these cases, the location of
scar is identified, but the value of the parameter does not accurately reflect
the heterogeneous presence of the dense scar and the gray zone.
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3.5 Evaluation on 120-lead ECG and Catheter Data
We conduct real-data study on two patients who underwent catheter ablation
of ventricular tachycardia due to prior tissue infarction as described in [66].
The patient-specific heart-torso geometry is constructed from 3D CT images.
The tissue excitability is estimated from 120-lead ECG using adaptive GPO,
adaptive BOBYQA, and uniform BOBYQA. Because uniform BOBYQA is
sensitive to initialization, we use the result of the global parameter estimation
to initialize this optimization. For validation of the result, we consider: 1)
the relation between the estimated tissue excitability and in-vivo epicardial
bipolar voltage data obtained from catheter mapping, and 2) the similarity
between the real ECG data and those simulated with the estimated tissue
excitability. Note that voltage data can be used only as a reference and not
the gold standard for the estimated tissue excitability.
Fig. 3.12 shows a comparison between the estimated tissue excitability and
the bipolar voltage data, in which the first column shows the original catheter
maps (red: dense scar, pink: healthy tissue), the second column shows the
catheter mapping registered to the CT-derived cardiac mesh (red: dense scar
≤0.5mV, green: scar border = 0.5 − 1.5mV, blue: normal > 1.5mV). The
catheter maps from patient case 1 reveal a dense scar on the basal lateral
region of the LV. As shown in Fig. 3.12, tissue excitability estimated using the
presented adaptive methods reveal abnormal tissues in the same region. In
this case, tissue excitability estimated using the uniform BOBYQA does not
align with the catheter maps. Similarly, the catheter maps from patient case
2 reveal a dense infarct distributed across the lateral and inferior LV regions.
As shown in Fig. 3.12, the tissue excitability estimated from the presented
methods and uniform BOBYQA successfully reveal the dense abnormal tissues
in this region. However, the estimation results from uniform BOBYQA also
shows some dense abnormal tissues in the apical region.
Fig. 3.13 shows a comparison of the real ECG data and those simulated
with the estimated tissue excitability on a few example leads. In patient
case 1, the simulated ECG fits the real ECG data on majority of the leads,
although the fit is poor on a few leads (see an example of a good and a poor
fit in Fig. 3.13(a)). The average RMSE between the simulated and real ECG
across all the leads is 0.2133mV. As shown in Fig. 3.13(b), in patient case 2, the
simulated ECG fits the real ECG data with lower accuracy: RMSE 0.4388mV.
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Figure 3.12: Real-data experiments. Estimated tissue excitability using the pre-
sented adaptive methods and uniform BOBYQA. In-vivo voltage maps are used as
reference data.
Figure 3.13: Real-data experiments. Comparison of the real ECG data and the
simulated ECG with estimated tissue excitability.
The limited data-fitting accuracy suggests the existence of modeling errors in
addition to that in the tissue excitability.
3.6 Discussion
3.6.1 Threshold for Adaptive Coarsening
In the presented framework, if the refinement of a parent node into two leaf
nodes does not yield a significant gain in the objective function, such refine-
ments are retracted. To do this, a threshold value in the gain of the objective
function must be pre-determined. We study the influence of this threshold
value using synthetic experiments on five different infarct cases. On each case
parameter estimation is done with the following values of the threshold: 0.1%,
0.5%, 1%, 5%, 10% and 20% of the maximum gain in global optimum at the
present resolution. The following observations are made: When a small value
of the threshold is used (0.1%), the refinements that contribute small gain
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Figure 3.14: Performance analysis of the presented framework: when threshold for
spatial coarsening changes from 0.1% to 20% of the maximum gain in global optimum
(left), and when two nodes vs. one node is split for spatial refinement (right).
to the global optimum are retained, resulting in a large number of unknowns
in the higher levels of the multi-scale hierarchy and a decreased ability to go
deeper into the multi-scale hierarchy. As a result, wider but shallower trees
are obtained. Alternatively, when a large value of the threshold is used (20%),
only those refinements that contribute a large gain in the global optimum are
retained, resulting in an increased ability to go deeper in the multi-scale hier-
archy but at the cost of accuracy. As a result, the final tree is narrower and
deeper. In overall, as shown in Fig. 3.14 left, a threshold value of 5% resulted
in good accuracy consistently.
3.6.2 Effect of Refining Multiple Nodes Versus a Single Node
Because an optimization method can accurately estimate only a limited dimen-
sions of unknowns in local parameter estimation, we choose to create spatial
partitions in the cardiac mesh sparingly. Thus, we refine a single node at
each scale. Alternatively, the refinement of more than one node could result
in a different final resolution of the cardiac mesh, and consequently different
parameter values. On eight synthetic experiments, we test the performance
of the presented method when one node is refined vs. when two nodes are re-
fined. As shown in Fig. 3.14 right, because the refinement of two nodes results
in a need to optimize a larger number of unknowns at each scale, there is a
decrease in the accuracy. The ability of the presented framework to go deeper
into the multi-scale hierarchy is also impacted.
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Figure 3.15: Left: comparison of the performance of the presented method when
empirical kernel parameters are used vs. when optimized kernel parameters are used.
Right: examples of estimation results using the presented method in the presence of
two infarcted tissue regions.
3.6.3 Parameters of the GPO
The GP is dependent on three kernel parameters: 1) the length scale ‘γ’, 2)
the covariance amplitude ‘α’, and 3) the observation noise ‘ς’ as described
in Section 3.2.2. The optimization of these kernel parameters along with
each update of the GP could result in higher accuracy. The most commonly
used approach is to maximize the marginal likelihood under the current GP,
p(J|θ1:n, α, γ, ς) = N (J|µ1,Kα,γ + ςI). As shown in Fig. 3.15 left, adap-
tive GPO with kernel parameter optimization does achieve higher accuracy
compared to that without. Therefore, we will include kernel parameter opti-
mization in the future development of the presented method.
3.6.4 Performance in the Presence of Two Infarcts
On six synthetic experiments, we test the performance of the presented frame-
work in the presence of two infarcts. As shown in Fig. 3.15 right, both the
infarcts are revealed. However, when two infarcts are spatially close some false
positives might be obtained at the narrow healthy tissue region separating the
two infarcts (Fig. 3.15 right case (c)). A large number of studies will be carried
out in future to investigate the performance of the presented framework in the
presence of multiple infarcts.
3.7 Conclusion
This chapter presented a novel framework that is able to estimate spatially-
varying parameters using a small number of unknowns, achieved through a
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coarse-to-fine optimization and a spatially-adaptive resolution that is higher
at heterogeneous regions. It is demonstrated on the estimation of local tis-
sue excitability in a cardiac EP model on both synthetic and real-data ex-
periments. Through comparison studies with optimization using pre-defined
segments, we show the ability of the presented framework in revealing het-
erogeneous tissue properties with higher accuracy. One improvement to this
framework is to improve its ability to go deeper and wider into the multi-scale
hierarchy. Another future step is to integrate the presented framework with





A common solution to reduce the dimension of unknown parameters is to par-
tition the anatomical mesh into a fixed small number of segments [83, 87].
In Chapter 3 we presented an alternative approach in which the partitioning
of the cardiac mesh into segments is obtained through a coarse-to-fine opti-
mization along a pre-defined multi-scale hierarchy of the cardiac mesh. Both
strategies are based on anatomy-based explicit partitioning of the cardiac mesh
into a set of segments. Without a priori knowledge of the distribution of the
tissues on the cardiac mesh, the low-dimensional (LD) parameter space thus
obtained could result in solutions that are either too low in resolution to reflect
tissue heterogeneity or too high in dimension to be reliably estimated.
In this chapter, we present a novel concept that embeds a generative vari-
ational auto-encoder (VAE) into the objective function of Bayesian optimiza-
tion, providing an implicit LD search space that represents the generative code
of the high-dimensional (HD) spatially-varying tissue properties. In addition,
the VAE-encoded knowledge about the generative code is further used to guide
the exploration of the search space. By embedding a generative process into
the objective function of a surrogate-based Bayesian optimization we are able
to embed both HD surrogate learning and active search of sample points into
a LD latent space enabling a HD surrogate-based Bayesian optimization.
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4.1 Introduction
Numerous works have been presented in estimating the spatially-varying tis-
sue properties in the form of high-dimensional (HD) model parameters. Most
existing methods choose to represent spatially-varying tissue properties via a
low-dimensional (LD) partitioning of the underlying geometrical model, either
as pre-defined segments [82], or iteratively optimized in a coarse-to-fine fash-
ion [17, 68]. This LD-to-HD definition directly exploits the spatial proximity
and hierarchical composition of the underlying geometry. However, it is of
such limited expressiveness that the number of partitioning is either too low
to faithfully represent high-resolution tissue properties, or too high to allow
effective optimization.
Here, we present a drastic alternative that replaces the explicitly defined
LD or multi-scale representation of the parameter space with an implicit
LD latent encoding. It is achieved by embedding within the optimization
a stochastic LD-to-HD generative model that describes the generation of the
HD spatially-varying tissue properties from a LD manifold. This generative
model is obtained with a variational auto-encoder (VAE), trained from a large
set of spatially-varying tissue properties reflecting regional tissue abnormal-
ity with various locations, sizes, and distributions. Once trained, the VAE
is integrated with a surrogate-based Bayesian optimization [7] in two novel
ways. First, the generative model (the VAE decoder) is embedded within the
objective function to provide an implicit LD search space for the optimization
of HD parameters. Second, the posterior distribution of the LD latent code
as learned from the VAE encoder is used as prior knowledge within the BO
for an efficient exploration of the LD manifold. To the best of our knowledge,
this is the first work that utilizes a probabilistic generative process within an
optimization framework for estimating HD patient-specific model parameters.
The presented method is applied to the estimation of local tissue ex-
citability of a cardiac electrophysiological model using non-invasive electro-
cardiogram (ECG) data. On both synthetic and real data experiments, the
presented method is compared against existing methods based on explicitly-
defined LD [83] or multi-scale representation of the parameter space [22]. Ex-
periments demonstrate that the presented method can achieve a drastic re-
duction in computational cost while improving the accuracy of the estimated
parameters. Beyond the specific model considered in this study, the presented
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method provides an efficient and reliable solution to a wider range of HD
model parameter estimation problems.
4.2 HD Parameter Estimation
The HD parameter θ in the electrophysiological model (2.1) can be estimated
by minimizing the sum of the squared errors between the measured physiologi-
cal signals Y and signals simulated by the composite of the electrophysiological
model and the measurement model: M(θ) = Hu(θ). This can be achieved by






To enable the estimation of θ at the resolution of the cardiac mesh, the pre-
sented method embeds within the Bayesian optimization framework a stochas-
tic generative model that generates θ from a LD manifold. It includes two
major components as outlined in Fig. 4.1: 1) the construction of a generative
model of HD spatially-varying tissue properties at the resolution of the cardiac
mesh, and 2) a novel Bayesian optimization method utilizing the embedded
generative model.
Figure 4.1: Outline of the Bayesian Optimization with an embedded Generative
Model, with the dimension of each VAE layer labeled.
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4.2.1 LD-to-HD Parameter Generation via VAE
Generative VAE model: We assume that the spatially varying tissue prop-
erties at the resolution of a cardiac mesh θ is generated by a small number of
unobserved continuous random variables z in a LD manifold. To obtain the
generative process from z to θ, the VAE consists of two modules: a probabilis-
tic deep encoder network with parameters α that approximates the intractable
true posterior density as qα(z|θ); and a probabilistic deep decoder network
with parameters β that can probabilistically reconstruct θ given z as pβ (θ|z).
Both networks consist of three fully-connected layers as shown in Fig. 4.1.





consisting of N configu-
rations of heterogeneous tissue properties in a patient-specific cardiac mesh.
The training involves optimizing the variational lower bound on the marginal
likelihood of each training data θ(i) with respect to network parameters α and
β :
L(α;β ;θ(i)) = −DKL(qα(z|θ(i))||pβ (z)) + Eqα(z|θ(i))[logpβ (θ
(i)|z)], (4.2)
where we model pβ (θ|z) with a Bernoulli distribution. To optimize Eq. (4.2),
stochastic gradient descent with standard backpropagation can be utilized.
Assuming the approximate posterior qα(z|θ) as a Gaussian density and the
prior pβ (z) ∼ N (0, 1), their KL divergence can be derived analytically as:




(1 + log(σ2j )−µ2j − σ2j ), (4.3)
where j is along the dimensions of z, and µ and σ2 are mean and variance
from qα(z|θ(i)). Because stochastic latent variables are utilized, the gradient of
the expected negative reconstruction term during backpropagation cannot be
directly obtained. The popular re-parameterization trick is utilized to express
z as a deterministic variable as z(i) = µ(i)+σ(i)ϵ, where ϵ ∼ N (0, I) is noise [43].
Probabilistic modeling of the latent code: The trained encoder pro-
vides an approximated posterior density of the LD latent code qα(z|θ). This
represents valuable knowledge about the probabilistic distribution of z learned
from a large training dataset. To utilize this in the subsequent optimization, we
integrate qα(z|θ) over the training data Θ to obtain the density qα(z) as a mix-
ture of Gaussians 1/N
∑N
i N (µ(i),Σ(i)), where µ(i) and Σ(i) are mean and co-
variance from qα(z|θ(i)). Because the number of mixture components in qα(z)
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scales linearly with the number of training data, we approximate qα(z) with a











Alternatively, we approximate qα(z) with a mixture of Gaussians with K <<
N components, where k-means clustering with the Bregman divergence [30]
as a similarity metric is used to reduce the number of mixture components.
In this way, we obtain a generative model pβ (θ|z) of HD tissue proper-
ties from an implicit LD manifold, and prior knowledge of the LD manifold
qα(z) from the probabilistic encoder. Both will be embedded into Bayesian
optimization to enable efficient and accurate HD parameter estimation.
4.2.2 Bayesian Optimization with Embedded Generative Model










which allow us to optimize the HD parameter θ in an implicit LD manifold of
z. For Bayesian optimization, we assume a zero mean Gaussian process (GP)
with an anisotropic Matérn 5/2 kernel as a prior over the objective function
(4.4). The optimization then consists of two iterative steps: 1) select point
in the LD manifold that allows the GP to globally approximate Eq. (4.4)
(exploration) while locally refining the area of optimum (exploitation); and 2)
update the GP.
VAE-informed Acquisition function: To select points on LD manifold,
we adopt the expected improvement (EI) function that picks a point with
maximum expectation of improvement over the current best objective function
value fm [7]. For a GP posterior ∼ N (µ(.), σ(.)), it can be obtained as:









where Φ and ϕ are the cumulative distribution function and density function
of the standard normal distribution. Here, the first term controls exploitation
(through high µ) and the second term controls exploration (through high σ).
Because using only fm can lead to excessive exploitation, it is common to
augment fm with a constant trade-off parameter ε as: fm + ε for increased
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exploration [7]. Here, we utilize the VAE-encoded knowledge about the LD
manifold qα(z) to enforce higher exploration in the areas of high probability





i (z −µi), where w, µ, and Σ are the weight, mean, and variance of the
K Gaussian mixture components in qα(z).
GP Update: After a new point z(n) is selected by maximizing the modified
EI, the objective function (4.4) is evaluated at the HD parameter given by
the mean of the generative model pβ (θ|z(n)). The GP is then updated by
adding the new pair of z(n) and objective function value, and maximizing the
log marginal likelihood with respect to kernel parameters: length scales and
kernel amplitude.
4.3 Evaluation on Synthetic Data
We include 27 synthetic experiments on three CT-derived human heart-torso
models. In each case, an infarct sized 2% − 40% of the heart was placed at
differing locations using various combinations of the American Heart Asso-
ciation (AHA) segments [9]. The value of the parameter θ in the infarcted
and the healthy region is set to 0.5 and 0.15, respectively. 120-lead ECG is
simulated and corrupted with 20dB Gaussian noise as measurement data. We
evaluate the accuracy in estimated parameters with two metrics: 1) root mean
square error (RMSE) between the true and estimated parameters; and 2) dice
coefficient (DC) = 2(|S1∩S2|)|S1|+|S2| , where S1 and S2 are the sets of nodes in the
true and estimated regions of infarct; these regions are determined by Otsu’s
thresholding method [55].
4.3.1 VAE Architecture and Training
For each heart, we generate a training dataset of tissue properties with various
heterogeneous infarcts. Each infarct is generated by random region growing
in which, starting with one infarct node, one out of the five closest neighbors
of the present infarct is randomly added to the infarct until an infarct of
desired size is obtained. It is then added to training data. Because infarcts
thus generated tend to be very irregular, we also include infarcts generated
by growing the infarct with the node closest to its center. For each heart,
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Figure 4.2: Comparison of BO-VAE EI Post-1 (blue bar) with: 1) FH and FS (green
bars); and 2) BO-VAE using standard EI, EI Isotropic, and EI Post-K (yellow bars)
in terms of DC, RMSE, and number of model evaluations (from left to right).
Figure 4.3: Left: Examples of estimated parameters with BO-VAE, FH, and FS.
Right: Progression of FH on the multi-scale hierarchy for parameter estimation of (a)
(green leaf: homogeneous tissues; red leaf: heterogeneous tissues).
we extract 123,896, 155,099, and 116,459 data. The training of VAE with an
architecture as shown in Fig. 4.1 with the Adam optimizer on Titan X GPU
took 9.77, 13.96, and 9.0 minutes for each dataset.
4.3.2 Comparison with Existing Methods
The presented method (termed as BO-VAE) is compared against two common
approaches based on explicit LD representation: 1) optimization over fixed
18 segments (fixed-segment (FS) method); and 2) coarse-to-fine optimization
along a fixed multi-scale hierarchy (fixed-hierarchy (FH) method). As summa-
rized in Figs. 4.2(a)-(b), BO-VAE (blue bar) is more accurate than the other
two methods (green bars) in both DC and RMSE (paired t-tests, p< 0.012).
This is achieved at a reduction of the computational cost by: 87.57% for the
FS method and 98.73% for the FH method (Fig. 4.2(c)).
As expected, the FS method shows the lowest accuracy: as illustrated
in Fig. 4.3, the estimated parameters either miss the infarct or include large
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Figure 4.4: Comparison of training points selected by EI (a) and EI Post-1 (b), and
examples of the estimated parameters by the two acquisition functions (c-d).
false positives. The FH method overcomes this issue, although only to a
limited extent. As shown in the final multi-scale representation obtained by
the FH method in the right panel of Fig. 4.3: several dimensions are wasted
at representing homogeneous healthy regions (green nodes) across different
scales, which limits its ability to optimize deeper along the tree. In contrast,
BO-VAE is not limited by such explicitly-imposed anatomy-based structure,
allowing it to attain higher accuracy with only two latent dimensions and
1-10% of the computation time.
4.3.3 The Effect of VAE-encoded Knowledge About the LD
Manifold
To study the effect of incorporating the VAE-encoded qα(z) in the EI function,
we compare the standard EI with EI augmented with three types of distribu-
tions on z: 1) pβ (z) ∼ N (0, 1) (EI Isotropic), 2) approximated qα(z) with a
single Gaussian density (EI Post-1); and 3) approximated qα(z) with a mix-
ture of 10 Gaussian densities (EI Post-K). As shown in Fig. 4.2, the estimation
accuracy using all three distributions is higher than that without using any,
among which EI Post-1 has the highest accuracy. Fig. 4.4 illustrates that,
when qα(z) is utilized, the exploration gradually proceeds from the region of
high probability density to the region of low probability density (Fig. 4.4(b)).
In comparison, with standard EI, the exploration is spread in an attempt to
reduce overall variance (Fig. 4.4(a)); this could result in incorrect (Fig. 4.4(c))
or suboptimal (Fig. 4.4(d)) solutions.
We also experimented with HD latent code z. As shown in Fig. 4.5(a)-
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Figure 4.5: (a-b): Examples of estimated parameters using five vs. two dimensional
latent codes. (c-d): Latent code manifold based on (c) infarct location, and (d) infarct
size.
Figure 4.6: Model parameter estimated with BO-VAE, FH, and FS on real-data
study.
(b), there was only a marginal improvement in accuracy with a five vs. a
two dimensional (2d) latent code. It suggests that, given the focus of the
training data on local infarcts, a 2d latent code may be sufficient to capture the
necessary generative factors. The plot of these 2d latent codes in Fig. 4.5(c)-(d)
show that they cluster by infarct location and their radial direction accounts
for the infarct size.
4.4 Evaluation on 120-lead ECG and Catheter Data
Real-data studies are conducted on two patients with previous myocardial
infraction. Patient-specific heart and torso meshes are constructed from axial
CT images. Tissue excitability is estimated from 120-lead ECG data. The
results are evaluated by in-vivo bipolar voltage data which, although not a
direct measure of tissue excitability, provides a reasonable reference about the
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region of infarcts. The first two columns of Fig. 4.6 show the original voltage
data (red: dense infarct; purple: healthy tissue; green: infarct border) and the
same data registered to cardiac meshes.
The voltage map in case 1 (Fig. 4.6(a)) shows a highly heterogeneous
infarct spread over a large region in the lateral LV. The estimated parameters
by all methods capture this region of infarct. For this accuracy, the FH and FS
methods required 4056 and 1058 model evaluations, whereas BO-VAE required
only 105 model evaluations. By contrast, as shown in Fig. 4.6(b), case 2 has
a smaller region of dense scar in the lateral LV. The estimated parameters by
BO-VAE and FH correctly reveal this region of scar, whereas the FS method
is less accurate. In this case, BO-VAE required 105 model evaluations in
comparison to the FH and FS methods that required 5798 and 1501 model
evaluations, respectively.
4.5 Conclusion
In this chapter, we presented a novel approach to estimating HD model param-
eters by optimizing their LD generative code, achieved by embedding within
the Bayesian optimization a generative model of HD tissue properties from a
LD manifold. Experiments show a gain in accuracy with drastically reduced
computation. Future improvements include two direction: 1) to incorporate
more realistic training data from high resolution 3D imaging for a more ex-
pressive generative model and potentially improved estimation of highly het-
erogeneous tissues; and 2) to investigate alternative means to incorporate the




Large Graphs via a Graph
Convolutional Generative
Model
Most previous works on parameter estimation as described in Chapters 2 and
3 rely on a geometry-based partitioning of the anatomical model to obtain a
low-dimensional (LD) representation of the spatially varying unknown tissue
properties in optimization. While these methods exploit the anatomical infor-
mation of the heart, the pre-defined set of partitions have limited ability to rep-
resent the complex tissue distribution and heterogeneity at a high-resolution.
Chapter 4 presented an alternative to utilize a variational auto-encoder as a
more expressive low to high-diemnsional (HD) generative model that allowed
to embed the HD optimization into the LD latent space. Its Euclidean nature,
however, neglects the rich anatomical information in the heart.
In this chapter, we present a novel graph convolutional generative model
to allow generative modeling of non-Euclidean data, and utilize it to em-
bed Bayesian optimization of large graphs into a small latent space. This
approach bridges the gap of previous works by introducing an expressive gen-
erative model that is able to incorporate the knowledge of spatial proximity
and hierarchical compositionality of the underlying geometry.
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5.1 Introduction
Numerous works have been presented in estimating spatially-varying tissue
properties in the form of high-dimensional (HD) model parameters for model
personalization. Most existing methods choose to represent spatially-varying
tissue properties via a low-dimensional (LD) partitioning of the underlying
geometrical model, either as pre-defined segments [32, 49, 63, 82, 83, 87], or
iteratively optimized in a coarse-to-fine fashion [10, 17, 68]. This LD-to-HD
definition directly exploits the spatial proximity and hierarchical composition
of the underlying geometry. However, it is of such limited expressiveness
that the number of partitioning is either too low to faithfully represent high-
resolution tissue properties, or too high to allow effective optimization.
By contrast the work in Chapter 3 presented the use of a data-driven gen-
erative model of HD tissue properties, via a variational auto-encoder (VAE),
to embed the optimization into a LD latent space [20]. Being more expres-
sive, this VAE-based generative model is able to represent high-resolution
tissue properties with a latent code sufficiently small for effective optimiza-
tion. However, as the regular VAE is defined over Euclidean data, it does not
take into account the valuable geometry information in the data, nor does it
allow transferring among different geometry without first establishing point-
by-point correspondence.
If we view organ tissue properties over a 3D geometrical model as an im-
age, convolutional neural networks (CNNs) are a natural choice to incorporate
knowledge of the spatial proximity and hierarchical composition of the im-
age [8]. However, standard CNNs have been most successful on data with an
underlying Euclidean structure (i.e., image grids). Generalizing CNNs to non-
Euclidean domains is an emerging area of research [8], where significant efforts
have been presented on addressing the challenges of defining convolution [28],
pooling, and up-sampling operations [85]. However, most developments to
non-Euclidean CNNs are focused on supervised discriminative networks. To
date, very limited work have been presented to enable generative modeling of
non-Euclidean data.
In this chapter, we present a novel VAE architecture that allows genera-
tive modeling of data over non-Euclidean domains, and utilize this generative
model to embed Bayesian optimization of large graphs into a LD manifold.
The presented approach bridges the gap of previous works by introducing
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an expressive generative model that is able to represent high-resolution tis-
sue properties with a small latent code, while incorporating the geometrical
knowledge in the data and being transferable across geometries. We evaluate
the presented method in synthetic and real-data experiments of estimating
tissue excitability in a cardiac electrophysiological model, where we compare
the expressiveness of the generative model and the accuracy of the subse-
quent parameter optimization with those obtained by using a linear recon-
struction model based on principal component analysis (PCA) and a regular
fully-connected VAE [20]. We further demonstrate the feasibility of transfer-
ring the presented non-Euclidean VAE across patients. To our knowledge, this
is the first introduction of a graph convolutional VAE and its use to enable
Bayesian optimization over large graphs.
5.2 Personalizing HD Parameters on Unstructured
Meshes
We seek parameter θ that minimizes the sum of squared errors between model




Directly solving (5.1) for the spatially-distributed θ is difficult [17]. Below
we describe how we learn a LD-to-HD generation of θ that accounts for the
underlying geometry, and embed the HD optimization into the expressive LD
manifold.
5.2.1 Graph Convolutional VAE
We model the generation of spatially-distributed θ with a VAE [43]. A VAE
consists a probabilistic encoder network with parameters α that approximates
the intractable true posterior density as qα(z|θ); and a probabilistic decoder
network with parameters β that represents the likelihood as pβ (θ|z). For data
defined on a Euclidean grid, structural information is incorporated in VAE
through CNNs. Here, we present a novel VAE architecture that enables con-
volution, pooling, and unpooling over non-Euclidean geometry of the heart.
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Figure 5.1: Outline of the presented method, with dimensions labeled within the
VAE.
Local Connectivity & Graph Convolution: We model the cardiac
mesh as a graph: G = (V, E ,U), where vertices V consist of all N meshfree
nodes and edges E exist between each meshfree node and its k nearest neigh-
bors. U ∈ [0, 1]N×N×3 consists of edge attributes υ(i, j), calculated as the
normalized (x1 − x2, y1 − y2, z1 − z2) if an edge (i, j) ∈ E exists between ver-
tices at (x1, y1, z1) and (x2, y2, z2) and 0 otherwise. On this graph, we use a
convolution operator based on spatial continuous convolution kernels because
it was shown to allow better generalization to similar graphs [28]. Specifically









where ((Nm1,i)1≤i≤k1 , . . . , (Nmd,i)1≤i≤kd) denotes d open B-spline bases of de-
gree m based on equidistant knot vectors with d-dimensional kernel size of
k = (k1, . . . , kd), P is the Cartesian product of the B-spline bases, and wp,l
are the trainable parameters. Given kernel functions g = (g1, . . . , gM ) and
input features f ∈ RM , the spatial convolution operator for each vertex i ∈ V
with a neighborhood N (i) based on its edge connectivity is then defined as:







Hierarchical Composition & Pooling: To define pooling and unpool-
ing operations necessary for the encoding-decoding architecture , a hierar-
chical representation of the graph is needed. We obtain this by an efficient
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multilevel graph clustering method based on minimizing the normalized cuts
(Graclus) [24], which reduces the graph size by half the number of vertices at
each coarsening.
We store hierarchical graph representation in matrices which reduces pool-
ing/unpooling operations to efficient matrix multiplications. Specifically if G
is a graph with N1 vertices and Gc is its coarsened graph with N2 < N1 ver-
tices, we populate a binary matrix PN1×N2 , where Pij = 1 if the ith vertex
in G was grouped to the jth vertex in Gc and Pij = 0 otherwise. Given M
feature maps F ∈ RN1×M over the vertices of graph G and Fc ∈ RN2×M over
graph Gc, the average pooling in the encoder can be obtained by Fc = PTnF
and unpooling in the decoder by F = PFc, where Pn is column normalized
from P.
Graph Convolutional VAE: Using these building blocks we construct
a VAE architecture as shown in Fig. 5.1. It is trained by optimizing the
variational lower bound on the marginal likelihood of the training data Θ =
{θ(i)}Ni=1: L(α;β ;θ(i)) = −DKL(qα(z|θ(i))||p(z)) +Eqα(z|θ(i))[logpβ (θ
(i)|z)]. We
set qα(z|θ) and pβ (θ|z) to be Gaussian parameterized by the graph convolu-
tional networks. The prior p(z) ∼ N (0, 1) is set to be an isotropic Gaus-
sian, producing an analytical form for the KL divergence. Using the re-
parameterization trick [43], standard stochastic gradient methods can be used
to optimize L(α;β ;θ(i)).
5.2.2 Bayesian Optimization on Large Graphs
Bayesian optimization is a popular choice in optimizing complex objective
functions such as (5.1) [7]. It begins by defining a surrogate over the objective
function. The optimization then consists of two iterative steps: 1) actively find
a point that optimizes a utility function based on the surrogate, and 2) update
the surrogate with the newly-selected point. Direct Bayesian optimization over
HD space is difficult and its use over large graphs has not been reported [7]. To








This allows us to embed surrogate construction and active selection of training
points in a LD manifold. We initialize the Gaussian process (GP) surrogate
of (5.4) with a zero mean function and an anisotropic Matérn 5/2 kernel.
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Active Selection of Training Points: To select a training point, we
maximize the expected improvement (EI) utility function that favours a point
with the highest expected improvement over the current optimum f+ [7]:











where µ(z) and σ(z) are the predictive mean and standard deviation of the
GP, Φ is the cumulative normal distribution, and ϕ is the normal density func-
tion. The first term promotes exploitation , while the second term promotes
exploration.
GP Update: After picking a new point z(i), the value of the optimiza-
tion objective (5.4) is evaluated at z(i) as J (i). The GP is then updated by
including the new input-output pair of (z(i),J (i)) and maximizing the log
marginal likelihood for kernel hyperparameters: length-scales and co-variance
amplitude.
5.3 Synthetic Experiments
We evaluate the presented graph convolutional VAE (termed as gVAE) by: 1)
its reconstruction accuracy, and 2) optimization accuracy of the gVAE-based
Bayesian optimization, both in comparison to existing methods. Accuracy is
evaluated by the sum of squared error (SSE) in θ, and the dice coefficient (DC)
of the abnormal region obtained by thresholding θ with Otsu’s method.
We synthetically generate data of heterogeneous tissue excitability via ran-
dom region growing in each cardiac model. Beginning with a single meshfree
node as abnormal, we randomly grow the abnormal region by adding one of the
nearest neighbors of the abnormal nodes, until the abnormal region reaches
a desired size (2% to 40% of the heart volume). On average, we generated
78, 208± 12, 541 data for training and 13, 545± 7654 data each for validation
and testing. The various layers and sizes of feature maps in each layer of the
presented gVAE architecture are detailed in Fig. 5.1. We use B-spline basis
degree of m = 1 with kernel size of k1 = k2 = k3 = 5 in all graph convolu-
tion layers. All models are trained with a learning rate of 0.001 with Adam
optimizer.
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SSE DC Trainable
parametersAnatomy 1 2 3 4 5 1 2 3 4 5
PCA 12.73 14.18 12.35 23.85 23.26 39.80 39.87 41.31 49.17 54.42 NA
fVAE-3h [20] 8.03 8.45 8.44 13.07 13.70 61.77 66.20 60.45 70.30 70.72 2,087,822
fVAE-4h 7.97 8.29 8.33 12.47 13.99 61.76 64.60 61.58 71.51 69.84 2,613,134
fVAE-5h 7.42 8.01 8.19 13.96 12.41 64.59 65.72 62.21 68.04 74.50 3,138,446
gVAE 6.66 6.89 6.79 11.28 11.43 68.43 70.92 70.70 75.10 76.86 2,778,069
Table 5.1: Comparison of reconstruction accuracy with the presented gVAE, PCA,
and fVAE with various depths [20] in five different geometries.
Figure 5.2: (a) Comparison of reconstruction accuracy using gVAE with a 2d mani-
fold vs. PCA and fVAE [20] with various-dimensional manifolds. (b)-(c): Plots of 2d
latent codes from gVAE colored by infarct location (b) and infarct size (c).
5.3.1 gVAE as a Generative Model
On five different human heart models constructed from CT images, we first
evaluate the ability of the presented gVAE model to reconstruct tissue ex-
citability in comparison to: 1) PCA-based linear reconstruction, and 2) fully-
connected VAE (termed as fVAE) [20] with three to five hidden layers (termed
as fVAE-3h, -4h, and -5h, respectively). As summarized in Table 1, PCA being
a linear model has the lowest accuracy. Compared to fVAE, the reconstruc-
tion accuracy of gVAE is consistently higher in both DC and SSE, even when
its number of trainable parameters is similar to or lower than fVAE. However,
gVAE is more expensive to train: 37.21 hrs vs. 7.51 mins for fVAE-3h in
TITAN Xp GPU. Nevertheless, note that the number of trainable parameters
for gVAE does not increase for larger meshes.
We further compare gVAE with two-dimensional (2d) latent codes vs.
fVAE and PCA with various latent dimensions. As shown in Fig. 5.2(a),
to achieve the reconstruction accuracy of gVAE with 2d latent codes, at least
13 principles components are required with PCA: this increase in dimension
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Figure 5.3: (a) Accuracy and (b) computational cost of gVAE (green) versus
fVAE [20] (yellow), FH [17] (purple), and FS [82] (red). (c)-(e): Examples of es-
timated parameters.
will make the subsequent optimization difficult. With fVAE, a similar SSE
is attained with four latent dimensions, while a similar DC could not be at-
tained with even 50 latent dimensions. This may be because fVAE does not
consider the geometry underlying the spatial distribution of tissue excitability.
Fig. 5.2(b) and (c) show that the latent code learned with gVAE are clustered
by the location of the abnormal tissue and its radial direction encodes the size
of the abnormal tissue.
5.3.2 gVAE-based Parameter Optimization
On 40 synthetic cases on two different heart geometries, we conduct experi-
ments on estimating unknown tissue excitability. In each case, we set an ab-
normal region by using various combinations of AHA segments which are very
different from the training set. Measurement data was simulated, sub-sampled
and corrupted with 20dB Gaussian noise. We compare the accuracy of gVAE-
based Bayesian optimization with three previous approaches: 1) optimization
on 17 fixed segments (termed as FS) [68, 82], 2) coarse-to-fine optimization
along a fixed multi-scale mesh hierarchy (termed as FH) [17], and 3) opti-
mization on a LD manifold obtained with fVAE-3h [20]. Result in Fig. 5.3(a)
shows that gVAE-based Bayesian optimization is more accurate than all other
approaches in both DC and SSE (paired t-test, p < 0.05). Fig. 5.3(c)-(f) shows
visual comparison on a few examples. The computational cost of gVAE-based
optimization is much lower than that of FH (> 22x) and FS (> 7.5x), and
similar to that of fVAE-based optimization.
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Figure 5.4: (a) Reconstruction accuracy and (b) convergence of test losses from
fine-tuned gVAE vs. gVAE trained from scratch (termed fully-trained) with varying
training data size. (c) Examples of estimated parameters using gVAE fine-tuned with
7360 data.
5.3.3 Feature Sharing Across Geometries
To demonstrate the feasibility of transferring the presented gVAE across dif-
ferent geometries, we take a pre-trained gVAE, fix the learned features in the
encoder’s graph convolution layers, and fine-tune the remaining layers for a
different anatomy. We compare this training strategy to training a gVAE from
scratch. Results in Fig. 5.4(a) show that a pre-trained model can be fined-
tuned with as small as 1088 new examples. In comparison, gVAE could not
be trained from scratch with ≤ 7360 samples, shown both by the low recon-
struction accuracy (Fig. 5.4(a): DC = 0.24; SSE = 17.68) and a flat test loss
plot (Fig. 5.4(b)). Test loss plots in Fig. 5.4(b) also show that a pre-trained
model starts with a lower loss and a larger size of training data leads to faster
convergence. Parameter optimization via a gVAE fine-tuned with 7360 data
on 20 cases achieved an average DC and SSE of 53.10 and 11.01 respectively.
Fig. 5.4(c) shows some examples of the estimated parameters.
5.4 Real Data Experiments
We conduct real-data studies on two patients with chronic myocardial infarc-
tion. Patient-specific heart-thorax models are obtained from axial CT images.
Using 120-lead ECG as measurements, we evaluate the presented gVAE in
estimating tissue excitability in comparison to the fVAE [20], FH [17], and
FS [82] methods. Training dataset and network architectures are as described
in Section 5.3. We qualitatively evaluate the results with in-vivo catheter map-
ping data which, as shown in Fig. 5.5, provides a reference for the location of
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Figure 5.5: Estimated parameters with gVAE, fVAE, FH, and FS on real-data stud-
ies.
the abnormal (red, voltage ≤ 0.5mV) and healthy (purple, voltage > 1.5mV)
regions.
Case 1 has a large heterogeneous abnormal region in the lateral LV region
(Fig. 5.5(a)). All methods are able to localize this region, but with varying
degree of heterogeneity. Optimizations based on gVAE and fVAE are much
faster requiring only 100 model evaluations, in comparison to FH and FS that
required 4056 and 1058 model evaluations, respectively. By contrast, case 2
has a smaller but dense abnormal region in the lateral LV (Fig. 5.5(b)). While
all methods identify the general location of this abnormality, gVAE more ac-
curately differentiates the region of dense core and border. In comparison,
fVAE and FH estimate a larger border region; and the abnormal region re-
vealed by FS is less accurate. Again, in this case, gVAE and fVAE required
only 100 model evaluations, whereas FH and FS required 5798 and 1501 model
evaluations, respectively.
5.5 Conclusion and Future Work
We presented a novel graph convolutional VAE model that allows generative
modeling of data defined over non-Euclidean structures and integrated it with
Bayesian optimization to enable Bayesian optimization on data defined over
large graphs. Experiments showed higher accuracy in both reconstructing the
tissue excitability and estimating them from indirect measurements in compar-
ison to existing baselines. A future direction is to incorporate realistic data
from high resolution 3D images and investigate transfer learning of models
trained on these data for accurate and efficient model personalization.
Chapter 6
Gaussian Process-based
Markov Chain Monte Carlo
In previous chapters we described several deterministic approaches to estimate
the high-dimensional (HD) patient-specific tissue properties in the form of
model parameters. However, significant uncertainty can be associated with
the estimated values of the model parameters which, if left unquantified, will
lead to unknown variability in the output of the physiological model that
will hinder their reliable clinical adoption. Probabilistic estimation of model
parameters, however, remains an unresolved challenge.
In this chapter, we present a novel approach on probabilistic estimation
of model parameters by integrating the surrogate modeling of the posterior
pdf of model parameters into accelerating the Metropolis-Hastings (MH) sam-
pling of the exact posterior pdf. It is achieved by two main components: 1)
construction of a Gaussian process (GP) surrogate of the exact posterior pdf
by actively selecting training points that allow for a good global approxima-
tion accuracy with a focus on the regions of high posterior probability density;
and 2) use of the GP surrogate to improve the proposal distribution in MH
sampling, in order to improve the acceptance rate.
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6.1 Introduction
The application of patient-specific modeling in clinical practice faces a crit-
ical barrier with respect to the variability in the simulation output. This
output variability arises from different sources of uncertainty inside the phys-
iological model when built from data. Primary sources of uncertainty include
the anatomy of the model (e.g., shape of the heart), tissue properties (e.g.,
excitability and contractility of the heart muscle), and boundary conditions.
Given the continued progress in high-resolution 3D imaging techniques, highly
accurate patient-specific models of the heart are now possible [4,68]. By con-
trast, the personalization of tissue properties faces several critical challenges
that can contribute to the uncertainty in the obtained patient-specific val-
ues. First, cardiac tissue properties typically cannot be directly measured;
they must be estimated from sparse, noisy, and indirect data. This results
in correlation and non-identifiability of tissue properties in different regions
of the heart. Second, it is impossible to estimate the tissue properties at
the resolution level of the discrete cardiac mesh and a representation of the
parameter space at a reduced dimension is necessary. The choice of different
low-dimensional (LD) representations will contribute to different uncertainties
in the resulting tissue properties of the patient-specific model. Hence, to rigor-
ously understand and quantify the variability and reliability of the predictions
made by a patient-specific model, it is important to properly quantify the un-
certainty associated with the model parameters that represent the estimated
tissue properties for each specific patient.
In the past few decades, significant progress has been made in determin-
istic approaches to parameter estimation. However, because these methods
focus on obtaining a single value of the model parameters that best fits the
available data (under given optimization criteria), they do not provide an un-
certainty measure associated with the estimated patient-specific parameter val-
ues. By contrast, limited progress has been made in probabilistic approaches
to estimating the patient-specific parameters of a cardiac model, where the
uncertainty in these parameters can be described by their posterior probabil-
ity density function (pdf) given the measurement data. This posterior pdf
of model parameters, in theory, could be estimated using standard Markov
Chain Monte Carlo (MCMC) methods that involve repeated non-intrusive
evaluations of the posterior pdf. Unfortunately, in this case, the posterior
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pdf consists of an analytically-intractable simulation model, each evaluation
of which evokes a computationally expensive simulation that could take hours
or even days to complete. As a result, it is infeasible to use standard MCMC
methods to obtain a posterior pdf of the parameters for expensive simulation
models [25,33,44].
In this chapter, we present a novel Gaussian process (GP)-accelerated
Metropolis-Hastings (MH) sampling framework to overcome the current chal-
lenges associated with the probabilistic estimation of patient-specific model
parameters. In this framework, a GP surrogate is built to approximate the
posterior pdf of the model parameters, which is then used to accelerate the
MH sampling of the exact posterior pdf. The key contributions of this work
include the following:
(i) We present a strategy of active GP construction that, rather than ran-
domly exploring the parameter space, actively selects training points to
approximate the posterior pdf with higher accuracy in regions of high
posterior density.
(ii) We present a mechanism that utilizes the efficient GP surrogate to mod-
ify and improve the proposal distribution of the MH sampling. Specif-
ically, the GP surrogate is utilized to initially test the acceptance for
each proposed candidate, and only those that are initially accepted will
be evaluated by the exact posterior pdf for final acceptance, eliminat-
ing the need to evoke the expensive simulation model at highly unlikely
candidates. This improves the acceptance rate of MH sampling without
compromising its accuracy.
(iii) We apply the presented framework to the probabilistic estimation of local
tissue excitability in a 3D cardiac electrophysiological (EP) model. Using
input data from simulated 120-lead electrocardiographic (ECG) data and
validation on synthetic infarct settings, we validate the accuracy and
establish its computational cost against direct MH sampling of the exact
posterior pdf. Further, we compare its performance with that of directly
sampling the surrogate posterior pdf as done in existing works [67]. Our
approach is also noteworthy in that limited work has been reported on
estimating tissue properties using non-invasive ECG data.
(iv) We further evaluate the presented method in estimating tissue excitabil-
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ity in a variety of experimental settings with different input data and
validation data. This includes using: 1) input data from a subset of
epicardial action potentials generated from an EP model blinded to the
presented estimation framework, with validation data of myocardial scar
from in-vivo magnetic resonance images (MRI); and 2) input data from
in-vivo 120-lead ECG data from post-infarction patients, with validation
data from in-vivo voltage mapping.
(v) We evaluate the presented estimation framework on two different LD
representations of the parameter space. We analyze the estimated pos-
terior pdf and demonstrate how the uncertainty of the obtained solution
is associated with the underlying dimensionality reduction method of
choice. This highlights the importance of quantifying the uncertainty in
estimated parameter values in patient-specific modeling.
(vi) We provide additional analyses of the estimated posterior pdf in relation
to other factors that may contribute to the uncertainty of the estimation
solution, including tissue heterogeneity, parameter coupling, and model
over-parameterization.
6.2 Probabilistic Parameter Estimation
A stochastic relationship between measurement data Y and model parameter
θ can be expressed as:
Y = M(θ) + ϵ, (6.1)
where M consists of the whole-heart electrophysiological model and the mea-
surement model as described in Section 2.1.2 and 2.1.3. ϵ is the noise term
that accounts for measurement error and modeling error other than that aris-
ing from the value of the parameter θ. Using Bayes’ rule, the unnormalized
posterior density of the model parameter θ has the form:
π(θ|Y) ∝ π(Y|θ)π(θ). (6.2)
Assuming uncorrelated Gaussian noise ϵ ∼ N (0, σ2eI), the likelihood π(Y|θ)








CHAPTER 6. GAUSSIAN PROCESS-BASED MCMC 64
Figure 6.1: Work-flow diagram of the presented framework.
where ||.|| is the Frobenius norm. The prior distribution π(θ) quantifies a priori
knowledge about the parameters. Here, a uniform distribution bounded within
[0, 0.52] is used. So, π(θ) is constant on this interval and 0 off it.
A direct MCMC sampling of the posterior pdf in Eq. (6.2) is infeasible be-
cause its slow convergence requires a significant number of evaluations of the
expensive electrophysiological model (at an order of 105). Below we present
an accelerated Metropolis-Hastings method that consists of two major ingredi-
ents. The first ingredient involves the rapid construction of a computationally-
efficient surrogate of the expensive posterior pdf (6.4) via active GP construc-
tion. The second ingredient involves the use of the efficient GP surrogate to
modify the proposal distribution in MH sampling in order to improve its ac-
ceptance and convergence rate. Fig. 6.1 shows a high-level work-flow of the
presented framework. In the following sections, we describe each component
in detail.
6.2.1 Active Construction of the GP Surrogate
Because of the analytic properties and the ability to provide probabilistic
prediction estimates, recently GP has found widespread use in active learn-
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ing [7,40,45,72] that is concerned with gathering the most informative training
data in cases in which collecting a large number of input-output pairs {Θ,G}
is prohibitively expensive [69]. In the context of this study, generating train-
ing pairs {Θ,G} for building the GP surrogate requires expensive evaluation
of the exact posterior pdf at each input θ. Therefore, a method for actively
selecting the training points from the parameter space is important. Below,
we describe the method that actively selects the training points to obtain an
approximation of the posterior pdf model that has higher accuracy in the
regions of high posterior pdf.
A GP fitted to the log-posterior pdf is typically better than a GP fitted to
the posterior pdf because, in general, the former has longer length scales and
lower dynamic range than the latter. Therefore, we fit a GP model for the log
of the un-normalized posterior pdf obtained by replacing π(Y|θ) in Eq. (6.2)
with Eq. (6.3) as given below:
g(θ) = − 1
2σ2e
||Y −M(θ)||2 + log(π(θ)). (6.4)
We first define a GP prior over the unknown function (6.4). Through the
co-variance function of a GP, assumptions about properties of the function
being modeled such as its smoothness and periodicity can be specified. Here,
we take an anisotropic Matérn 5/2 co-variance function [60] that enforces an
assumption of twice differentiable function:













where d2(θi, θj) = (θi−θj)⊺Λ(θi−θj), Λ is a diagonal matrix with the square
of the characteristics length scales along each dimension of θ as the diagonal
elements, and α2 is the co-variance amplitude. Because no prior knowledge
about the posterior pdf is available, here for simplicity we take a zero mean
function, which is a commonly and effectively used mean function in GP mod-
eling [60]. The active construction of GP consists of an iteration of two major
steps: 1) find a point in the sample space that improves the approximation
of Eq. (6.4), especially in the regions of high posterior pdf, and 2) update the
GP at this point.
1. Find optimal training points in the parameter space to update the GP:
Here, we assume that the optimal training points are those that will: 1) allow
the GP to globally approximate the Eq. (6.4) well, and 2) identify the regions
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of high posterior probability. For the former, points are chosen where the
predictive uncertainty σ(θ) of current GP is high (to facilitate exploration of
uncertain space). For the latter, points are chosen where the predictive mean
µ(θ) of the current GP is high (to exploit the current knowledge about the
space of high posterior probability). This is done by finding the point that







The parameter β = 2 log(π2n2/6η), η ∈ (0, 1) balances between exploitation
and exploration of the parameter space [7, 71]. Eq. (6.6) is optimized using
a bound constrained derivative-free optimization method known as Bound
Optimization BY Quadratic Approximation (BOBYQA) [58]. The predictive
mean and uncertainty in Eq. (6.6) are evaluated using Eq. (2.4).
2. Updating the GP surrogate at selected training points: Once a new
training point is obtained, Eq. (6.4) is evaluated at this point and the GP
is updated at the newly obtained {θn+1, gn+1} pair. This GP captures the












where k = [κ(θn+1, θ1), κ(θn+1, θ2), · · ·κ(θn+1, θn)]T, K is the co-variance ma-
trix, and ς = 0.001 is a small noise term that is added for numerical stabil-
ity. After every several updates of the GP, we optimize the hyperparameters
(length scales Λ and covariance amplitude α) by maximizing the marginal
likelihood log p(g1:n+1|θ1:n+1, α,Λ).
These two steps iterate until the training point selected by optimizing the
upper confidence bound (6.6) changes little over a few iterations (≤ 0.005,
15 iterations). The hyperparameters length scales Λ and covariance ampli-
tude α are once again optimized by maximizing the marginal likelihood log
p(g1:n+1|θ1:n+1, α,Λ). Fig. 6.2 gives examples of the training points selected
during the GP construction, which reveals that these points are spread in
the sample space but are more concentrated in the regions of high posterior
probability. We take the predictive mean function of the resulting GP as the
surrogate of Eq. (6.4). In this way, we can obtain a GP-based surrogate of the
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Figure 6.2: Examples of exact bivariate marginal pdfs superimposed with the train-
ing points collected during GP construction, which are spread in the parameter space
but are most concentrated in regions of high probability density.
exact posterior pdf π(θ|Y), denoted by π∗(θ|Y) for the remainder of this chap-
ter, that is cheap to evaluate and is most accurate in regions of high posterior
probability.
6.2.2 GP Surrogate Accelerated Metropolis-Hastings
MH is the most widely used MCMC method. It begins from an arbitrary
sample θn and generates a Markov chain of samples that come from an invari-
ant distribution. Specifically at each step in the MH algorithm, a candidate
sample θc is proposed using a proposal distribution q(θc|θn). This candidate
is accepted with a probability given by:







If accepted, θn+1 = θc. If rejected, θn+1 = θn. This is repeated until the
samples converge to the target distribution.
The success of the MH largely relies on the choice of the proposal distribu-
tion. If the proposal distribution is much narrower than the target distribution,
the MH will spend too much time exploring the sampling space, resulting in
bad mixing. Conversely, if the proposal distribution is much wider than the
target distribution, the MH will make wide jumps in the sampling space, re-
sulting in a large number of rejections. Ideally, a proposal distribution similar
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to the target distribution is desired for a higher acceptance rate with a good
mixing. However, to obtain such a proposal distribution is notoriously difficult
and a Gaussian distribution is the most commonly used proposal distribution
in practice. Meanwhile, some previous works have proposed the modification
of this generic proposal distribution using various approximate target distri-
butions [12, 25]. Below, we describe how a GP surrogate of the posterior pdf
is utilized to modify the Gaussian proposal distribution in MH to accelerate
sampling with good mixing and a higher acceptance rate.
Specifically, we present a two-step test of acceptance. In the first step, a
candidate θc1 proposed by a standard Gaussian proposal distribution q(θc1|θn)
is tested for acceptance by the GP surrogate of the posterior pdf π∗(θ|Y) with
acceptance probability given by:







The candidate for the second test of acceptance is determined by the out-
come of the previous step, i.e, θc = θc1 if accepted and θc = θn if rejected. In
other words, the candidates for the second step are effectively generated from
the transition probability in the first step, which defines the effective proposal
distribution for the second step:
q∗(θc|θn) = ρ1(θn, θc)q(θc|θn) + r(θn)δθn(θc), (6.10)
where r(θn) = 1 −
∫
ρ1(θn, θc)q(θc|θn)dθc is the probability that the chain
remains at θn and δθn(.) denotes the Dirac mass at θn. Using this modified
proposal distribution, the proposed candidate sample is accepted by the exact
posterior pdf with a probability given by:







Depending on whether the candidate was accepted or rejected in the first
step, the acceptance rate in Eq. (6.11) can be calculated. When a can-
didate is accepted in the first step, i.e., θc = θc1, we obtain q∗(θc|θn) =
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Substituting Eq. (6.12) into Eq. (6.11), the acceptance probability in the
second step can be simplified to:







When a candidate is rejected in the first step, then θc = θn and ρ2(θn, θc) = 1.
In other words, samples that are rejected in the first step do not need to be
evaluated by the exact posterior pdf. This improves the proposal distribution
for the MH method and reduces the need for evaluating the expensive posterior
pdf at candidates that are highly unlikely to be accepted.
Convergence of the GP-accelerated MH Sampling: The convergence
of the MH with modified proposal distribution follows the same line as that
of the standard MH [3,12,25,33]. Given any initial sample, the Markov chain
generated by the MH converges to an invariant distribution if the transition
probability meets the following properties: 1) irreducibility, and 2) aperiod-
icity. A sufficient, but not necessary, condition to ensure convergence to an
invariant distribution is reversibility (detailed balance). The presented GP-
accelerated MH satisfies these criteria as follows:
1) Reversibility: Similar to the standard MH, through the inclusion of the
acceptance rate, the transition probability is designed to meet the criteria of
detailed balance by construction. Specifically, the detailed balance condition
is given by:
π(θn|Y)T (θc|θn) = π(θc|Y)T (θn|θc). (6.14)
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where T denotes the transition probability of the presented GP-accelerated
MH method that is defined by:









Proof. When θc = θn, Eq. (6.14) is automatically satisfied. When θc ̸= θn,
Eq. (6.14) can be simplified using Eq. (6.15) and Eq. (6.11) as:














2) Aperiodicity: Because the acceptance criteria in the presented method
always allow for rejection of the samples as in the standard MH, the presented
GP-accelerated MH is also aperiodic.
3) Irreducibility: If π(θc|Y) > 0, ∀θc ∈ Ω implies π∗(θc|Y) > 0, ∀θc ∈
Ω, where Ω is the support of the exact posterior pdf π(θc|Y), then the Markov
chain generated by the presented method is π-irreducible.
Proof. To ensure the condition of irreducibility in the standard MH, the pro-
posal distribution is chosen to satisfy q(θc|θn) > 0, ∀θc, θn ∈ Ω. As a re-
sult, the transition probability in the standard MH, Tmh(Ω|θn) > 0, ∀θn ∈
Ω. Using the condition that the GP surrogate of the posterior distribution
π∗(θc|Y) > 0, ∀θc ∈ Ω, we can obtain similar results for the transition prob-
ability in the first step (alternatively the proposal distribution for the second
step) of the presented method, i.e., q∗(θc|θn) > 0, ∀θc, θn ∈ Ω. With-
out the loss of generality, assuming that θc ̸= θn, we obtain q∗(θc|θn) =
ρ1(θn, θc)q(θc|θn) > 0, ∀θc, θn ∈ Ω from Eq. (6.10). This implies that
ρ2(θn, θc)q
∗(θc|θn) > 0, ∀θc, θn ∈ Ω. Therefore, the effective transition
probability Eq. (6.15) of the presented method T (θc|θn) > 0, ∀θc, θn ∈ Ω.
Hence, under the given condition that π∗(θc|Y) > 0, ∀θc ∈ Ω, the presented
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method is π-irreducible. Here, the GP surrogate of the posterior distribution
π∗(θc|Y) is an exponential function. Therefore, π∗(θc|Y) > 0, ∀θc ∈ Rd.
In practice, while the theoretical convergence is guaranteed, an inaccurate
surrogate model could lead to a biased sampling with a low acceptance rate
in the presented method.
6.3 Evaluation on Synthetic Data
In experiments with synthetic data, we first evaluate the accuracy and effi-
ciency of the presented method (GP-accelerated MH) against: 1) the baseline
of directly sampling the exact posterior pdf using the standard MH (direct
MH), and 2) the previously reported approach of directly sampling the surro-
gate posterior pdf using the standard MH (MH on GP) [67]. We then analyze
and interpret the obtained posterior pdfs in relation to different factors con-
tributing to parameter uncertainty, primarily under the setting of parameter
estimation using two different LD representations of the spatial parameter
space as described in Chapter 3.
In total, we consider 14 synthetic cases with seven different settings of
infarcts, each of which is estimated on two different LD representations of
the spatial parameter space. To represent healthy and infarcted tissues in
each case, the parameter a of the AP model (2.1) is set to 0.15 and 0.50,
respectively. Measurement data for parameter estimation is generated in two
steps. First, action potentials on the cardiac mesh are simulated using the AP
model (2.1). Then, 120-lead ECG are generated using the forward model (2.2)
and corrupted with 20 dB Gaussian noise.
All MCMC sampling runs on four parallel MCMC chains of length 20,000
with a common Gaussian proposal distribution and four different initial points.
The variance of the Gaussian proposal distribution is tuned by rapidly sam-
pling the GP surrogate pdf until obtaining an acceptance rate of ∼ 0.22, which
is documented to enable good mixing and faster convergence in higher dimen-
sional problems [3, 33]. The four initial points are obtained by conducting
a rapid sampling of the GP surrogate pdf, constructing four clusters of the
samples using a Gaussian mixture model, and using the mean of each as the
starting points for each chain. After discarding initial burn-in samples and se-
lecting alternate samples to avoid auto-correlation in each chain, the samples
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from four chains are combined. The convergence of all the MCMC chains is
tested using trace plots, Geweke statistics, and Gelman-Rubin statistics [3,33].
To differentiate the infarcted and healthy regions from the estimated tissue
properties, we calculate a threshold value that minimizes the intra-region vari-
ance on the estimated parameter values [55].
6.3.1 Validation of the Accuracy and Efficiency
We first validate the accuracy of the presented method against directly sam-
pling the exact posterior pdf using the standard MH method. Fig. 6.3 presents
four examples of posterior pdfs obtained from different synthetic data cases.
As shown, the presented sampling strategy (green curve) closely reproduces
the true posterior pdf (red curve) obtained from direct MH.
Next, we compare the computational cost of the presented method with
that of the direct MH in terms of the number of model evaluations needed and
actual computation times. The comparison is based on 14 synthetic cases run
on a computer with a Xeon E5 2.20 GHz processor and 128 GB RAM. The
presented method reduces the number of model evaluations by an average
of 64.47% despite the overhead of constructing the GP surrogate which, as
highlighted in the purple bar in Fig. 6.4 left, is very small compared with the
number of model evaluations required for sampling. The computation time is
reduced from 41.073±2.028 hours with direct MH to 7.961±2.028 hours with
the presented method.
The efficiency of the sampling method is also measured in terms of its
acceptance rate. Here, acceptance rate refers to the fraction of the accepted
candidates out of all those proposed to the exact posterior pdf. As shown in
the right panel of Fig. 6.4, the presented method improves the acceptance rate
from 0.2653±0.0500 of the direct MH to 0.3988±0.0788. This means that the
presented method is able to improve the proposal distribution by filtering out
a large portion of candidate samples that would eventually be rejected by the
exact posterior pdf, thereby avoiding evoking expensive simulation models on
these candidates.
6.3.2 Comparison with Directly Sampling the GP Surrogate
Directly sampling the GP surrogate pdf instead of the exact pdf, as commonly
done in existing methods [67], requires significantly less computation because
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Figure 6.3: Examples of the exact posterior pdfs (red) vs. those obtained by the
presented method (green) and sampling the GP surrogate pdf (blue).
Figure 6.4: Comparison of the efficiency between the presented method (GP-
accelerated MH) and the standard MH method (Direct MH). Left: computational
cost. Right: acceptance rate.
model simulation is not needed. However, the sampling accuracy also becomes
critically reliant on the accuracy of the surrogate model. As illustrated in the
examples in Figs. 6.3(c) and 6.3(d), sampling the GP surrogate (blue curve)
produces a distribution that is different from the exact pdf not only in general
shape but also in locations of the mode. In comparison, while the accuracy in
the GP surrogate affects the efficiency of the presented method, the estimated
pdf converges to the exact pdf as obtained by the direct MH. Using the mean,
mode, and standard deviation of the exact pdf as the baseline, Table 6.1 shows
that sampling errors of the presented method are significantly lower than those
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Table 6.1: Mean absolute errors in the estimated mean, mode, and standard devi-
ation against directly sampling the exact posterior pdf: the presented method (GP-
accelerated MH) vs. sampling the GP surrogate pdf only (MH on GP).
Method Mean Mode Standard deviation
GP-accelerated MH 0.012 0.030 0.006
MH on GP 0.039 0.058 0.015
from sampling the surrogate only (paired t-test on 139 estimated parameters,
p < 0.001).
6.3.3 Analysis of the Sampled Posterior Distributions
Several factors can contribute to the uncertainty in the estimated model pa-
rameters, including but not limited to the sparse measurement data, parame-
ter correlation, model over-parameterization, and limited spatial resolution in
comparison with the underlying tissue heterogeneity (which we will refer to
as “model under-parameterization” for the remainder of the chapter). Some
of these factors vary with the method used to represent the parameter space.
For example, different LD representations of the parameter space may result
in different correlations between each dimension of the parameter, as well as
different over- and/or under-parameterization of the model. Therefore, in this
section, we consider the presented approach on two types of LD representa-
tions of the parameter space: a uniform division of the cardiac mesh into 10
segments using the AHA standard, and a non-uniform division of the car-
diac mesh into 7-15 clusters using a method that aims to adaptively group
homogeneous nodes of the cardiac mesh together [22]. Below, we analyze
and interpret the estimated posterior pdfs in relation to the aforementioned
contributing factors to uncertainty. We elaborate on three examples with a
varying degree of “parameter heterogeneity”, a term we use to denote a state
in which a dimension of the parameter representation is too low in resolution
to reflect the underlying heterogeneity.
In the first example shown in Fig. 6.5, the infarct in the septum region is
better represented by the uniform method than the adaptive method with re-
spect to parameter heterogeneity. Specifically, the uniform method generates
three heterogeneous segments that are 37.32% of the heart volume; in com-
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Figure 6.5: Examples of parameter estimation results when using clusters from the
adaptive method vs. segments from the uniform method as LD representation of the
spatial parameter space. Case 1, case 2, and case 3 respectively show an example
in which the infarct is represented better by the segments, equally by both segments
and clusters, and better by the clusters in terms of parameter heterogeneity.
parison, the adaptive method generates four heterogeneous clusters that are
53.09% of the heart volume. In this case, the mode estimated using the uni-
form method accurately captures the infarct region (Dice coefficient: 0.5896),
whereas the adaptive method captures the infarct with false positives at the
right ventricle (Dice coefficient: 0.3447). Correspondingly, while the uniform
method shows high confidence in the solution obtained in the region of true
infarct, the adaptive method shows high uncertainty in the region of true in-
farct. In addition, it is interesting to note that both LD representations result
in high parameter uncertainty at the right ventricle region and the anterior
region adjacent to the region of infarct. This uncertainty, independent of the
LD representation of choice, may indicate difficulty in estimating parameters
in this region of the heart due to non-identifiability and limited measurement
data.
In the second example that has an infarct in the anterior region as shown in
Fig. 6.5, both the uniform and adaptive methods show similar parameter het-
erogeneity in representing the infarct. Specifically, with the uniform method,
the infarct lies completely within a segment such that only one segment that
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is 10.42% of the heart volume contains heterogeneous tissue; in comparison,
the adaptive method generates three heterogeneous clusters that is 10.16% of
the heart volume. As shown, using the uniform method, the estimated mode
reveals higher parameter value in the segment that contains the infarct (Dice
coefficient: 0.1622) with high confidence. However, the standard deviation
plot shows high uncertainty in the estimated parameters throughout the car-
diac mesh, possibly to compensate for the fact that the true infarct is much
smaller than the segment representing the infarct. In comparison, using the
adaptive method, the estimated mode has high parameter value in a narrower
region representing the compact infarct with higher accuracy (Dice coefficient:
0.5763). Likewise, high parameter uncertainty is obtained in a more concen-
trated region that overlaps the heterogeneous clusters. Additionally, similar
to the first example, both LD representations show high uncertainty in the
region that is adjacent on the left to the region of true infarct. This indicates
difficulty in accurately estimating parameters in those regions, possibly again
due to non-identifiability and limited data.
Finally, Fig. 6.5 case 3 shows an example in which an infarct is better
represented by the adaptive method than the uniform method with respect to
parameter heterogeneity. Specifically, uniform method generates five segments
with heterogeneous tissue, totaling 45.01% of the heart volume; in comparison,
the adaptive method also generates five clusters with heterogeneous tissue,
but totaling only 30.59% of the heart volume. In this case, the mode obtained
using the adaptive method captured the region of infarct with higher accuracy
(Dice coefficient: 0.6220) than the mode obtained using the uniform method
(Dice coefficient: 0.3269). A closer look at the standard deviation plots reveals
that, in general, high uncertainty is obtained in the regions of heterogeneous
tissue when using either method. Overall, because a higher proportion of the
cardiac mesh is associated with heterogeneous representations when using the
uniform method (model under-parameterization), an overall larger region of
high parameter uncertainty is obtained with the uniform method compared
with the adaptive method.
While the issue of model under-parameterization is more evident with the
uniform method as explained above, the issue of model over-parameterization
is more evident with the adaptive method. This is because the adaptive
method as described in [17] could result in a large number of small clusters at
heterogeneous regions around the infarct. Consequently, parameter values at
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Figure 6.6: Example of high uncertainty associated with over-parameterization when
the adaptive method assigned several small clusters to represent the heterogeneous
regions around the infarct (c-e). Top row: clusters represented by one dimension
of the parameter space. Middle row: univariate marginal density plot of the esti-
mated parameter. Bottom row: estimated mean, mode and standard deviation of the
parameter.
these regions are associated with a high uncertainty as seen in the standard
deviation plots obtained by using the adaptive method in Fig. 6.5, likely due
to the issue of non-identifiability given limited and indirect measurement data.
An example case, in which this issue is more pronounced, is shown in Fig. 6.6.
Here, several small clusters (c-e) are formed by the adaptive method at the
region of the inferior-lateral infarct and its border. For parameter values at
these clusters, the MH sampling has difficulty converging to a distribution
with distinct modes, which is reflected as high uncertainty in the resulting pa-
rameter values. These examples show that probabilistic parameter estimation
can help reveal the issue of identifiability, which cannot be observed when a
single point estimate is being sought.
Finally, different LD representations of the parameter space can also result
in different correlations among the parameters in each dimension. In Fig. 6.7,
we show an example with an infarct localized in the septal region, in which
the parameter of one of the regions shows both a positive correlation and a
negative correlation with parameters in other regions. As shown at the top
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Figure 6.7: (a) Regions of the heart obtained by the adaptive method (red: infarct,
green: non-infarct/mixed). (b) Estimated univariate and bivariate marginal pdf plots.
(c) Trace plot for parameters of regions 6 and 7 (top) shows a negative correlation
with a switching behavior, whereas that of regions 5 and 7 (bottom) shows a positive
correlation.
of Fig. 6.7(c), the parameter in region 7 and region 6 exhibits a negative
correlation with a switching behavior (i.e., when the parameter in region 7
is estimated in a healthy range, the parameter in region 6 is estimated in an
unhealthy range). At the same time, the parameter in region 7 and region 5
exhibit a positive correlation (i.e., when the parameter in region 7 is estimated
in a healthy range, the parameter in region 6 also is estimated in a healthy
range; Fig. 6.7(c), bottom). This is reflected as higher parameter uncertainty
in all three regions.
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6.4 Evaluation on a Blinded EP Model and In-vivo
MRI Scar
In this section, we study the presented method in quantifying the uncertainty
in model parameters for post-infarction human hearts, where validation data
for the 3D myocardial infarct is available from in-vivo magnetic resonance
imaging. Compared with the infarct settings in synthetic data experiments,
these MRI-derived 3D infarcts have the following characteristics that increase
the heterogeneity in tissue properties: 1) the presence of both dense scar core
and gray zone, 2) the presence of a single or multiple scars with complex spatial
distribution and irregular boundaries, and 3) the presence of both transmural
and non-transmural scars. The resolution to which such heterogeneity can be
captured is largely limited by the method of dimensionality reduction. Because
previous work has shown that an adaptive non-uniform LD representation may
be able to better represent tissue heterogeneity [17], the experiments below are
conducted using only the adaptive LD representation of the parameter space.
Because in-vivo electrical mapping data were unavailable, here measurement
data for probabilistic parameter estimation are generated by a high-resolution
(average resolution: 350 µm) multi-scale (sub-cellular to organ scale) in-silico
ionic electrophysiological model on the MRI-derived patient-specific ventric-
ular models as detailed in [4]. Data used for parameter estimation are ex-
tracted from 300-400 epicardial sites, temporarily down-sampled to a 5 ms
resolution, and corrupted with 20 dB Gaussian noise. Note that although no
in-vivo electrical data were available, the experiments are designed to mimic a
real-data scenario because: 1) the 3D EP model used to generate the measure-
ment data is known to be capable of generating high-fidelity EP simulation
of patient-specific hearts [4], 2) this model is unknown to the framework of
GP-accelerated MH and thus no “inverse crime” is involved, and 3) only a
small subset of epicardial data corrupted with noise is used as measurement
data.
For clarity, below we analyze the performance of the presented method
with respect to two contributing factors to the heterogeneity of the scar: 1)
scar transmurality, and 2) gray zone. For ground truth, these regions were
determined from the 3D infarcts mapped to the high resolution cardiac mesh
from MRI [4].
1) Scar transmurality: In examples case 1, case 2, and case 3 shown in
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Figure 6.8: Mean, mode, and standard deviation of posterior pdfs estimated from
epicardial potentials simulated by a multi-scale ionic EP model blinded to the pre-
sented estimation method. Purple circles denote areas of non-transmural scars (cases
1, 2, and 3) or gray zones (cases 4 and 5).
Fig. 6.8, a portion of the scar is non-transmural. From left to right, the non-
transmural portion of the scar lies respectively on the lateral wall, the anterior-
septal region, and the anterior-lateral wall of the left ventricle as denoted by
a purple circle. In all three cases, the estimated mode misses these regions
of non-transmural scar; the estimated mean exhibits higher parameter values
deviating from that for healthy tissue, yet the value is not as high as that for
scar tissue. In all cases, parameter values in these regions are associated with
high uncertainty. This provides a useful confidence measure for the estimated
mode, suggesting that these regions do not consist entirely of healthy tissue
as reflected by the mode.
2) Gray zone: Case 4 and case 5 in Fig. 6.8 show examples in which a
transmural dense scar is surrounded by gray zone. In both cases, the mean
and mode estimates obtain high parameter values in the region of dense scar
and gray zone. The parameter values in the regions of dense scar are higher
than those in gray zones. In addition, the mean estimates reveal the gray zone
to be wider than the estimates from MRI data, whereas the mode estimates do
not. Parameters for these border regions are associated with high uncertainty
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Figure 6.9: Mean, mode, and standard deviation of the posterior parameter pdfs
estimated from 120-lead ECG data.
as shown in the standard deviation plots, reflecting the underlying tissue het-
erogeneity in these regions and the possible model under-parametrization as
a result of the LD representation of the parameter space.
6.5 Evaluation on 120-lead ECG and Catheter Data
We conduct real-data studies on three patients who underwent catheter ab-
lation of ventricular tachycardia due to prior myocardial infarction [66]. The
patient-specific heart-torso geometrical models are constructed from axial com-
puterized tomography images. The uncertainty of tissue excitability in the AP
model (2.1) is estimated from 120-lead ECG. Similarly, all experiments are
conducted using the adaptive LD representation of the parameter space [17].
For validation of the results, we consider the relation between the estimated
tissue excitability and the in-vivo epicardial bipolar voltage data obtained
from catheter mapping. It should, however, be noted that voltage data can
be used only as a reference, not as the gold standard for the measure of tis-
sue excitability. Below we focus our analysis on how the obtained parameter
uncertainty is associated with the heterogeneity of the underlying tissue.
Case 1: The voltage data for case 1 (Fig. 6.9(a)) shows a dense infarct
at inferolateral left ventricle (LV) with a heterogeneous region extending to
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Figure 6.10: Real-data experiments for case 1 from Fig. 6.9: regions of the heart to
be parameterized and the corresponding marginal probability density plots.
lateral LV. Adaptive dimensionality reduction as described in [17] generates
eight regions of the heart to be parameterized, five of which are listed in
Fig. 6.10 along with the estimated posterior marginal pdfs for their parameters.
As shown, the parameter for the region of infarct core (a) is correctly estimated
with high confidence. The parameter for the region of immediate border to
the infarct (e) has a mean/mode value that is in between the healthy and
infarct core, correctly indicating a border zone, whereas other regions in the
infarct border are estimated as either healthy (c-d) or infarcted (b). For all
these regions around the heterogeneous infarct border (b-e), uncertainties of
the estimation are higher. This produces an estimation with correct posterior
mode/mean with high confidence at the infarct core, and high uncertainty at
the heterogeneous infarct border.
Case 2: The voltage data for case 2 (Fig. 6.9(b)) shows a massive yet quite
heterogeneous infarct at lateral LV. The adaptive dimensionality reduction
method generates 12 regions of the heart to be parameterized, five of which are
listed in Fig. 6.11 along with the estimated marginal pdfs for their parameters.
As shown, for remote healthy regions (a-b), their parameters are correctly
estimated with high confidence. For heterogeneous border regions close to
the infarct (c-d), their parameters are estimated in the healthy range but
with lower confidence. For the region that corresponds to the infarct (e),
its abnormal parameter is correctly captured but with a high uncertainty –
likely reflecting the heterogeneous nature of tissue properties in this region.
As summarized in Fig. 6.9(b), while the estimation correctly reveals the region
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Figure 6.11: Real-data experiments for case 2 from Fig. 6.9: regions of the heart to
be parameterized and the corresponding marginal probability density plots.
of infarct as in case 1, it is also associated with a higher uncertainty compared
with the less heterogeneous infarct in case 1.
Case 3: The voltage data for case 3 (Fig. 6.9(c)) shows low voltage at lat-
eral LV and RV, although it was not certain whether the low voltage on lateral
RV was due to the presence of an infarct or fat layer. After dimensionality
reduction with the adaptive method, there are seven regions of the heart that
remain to be parameterized (Fig. 6.12(a)). The infarct region in lateral LV
(region 1) is estimated with a distribution that has medium uncertainty and a
mode of 0.257. This could indicate the presence of infarcted tissue along with
some healthy tissue (heterogeneity). In contrast, the marginal distribution for
the healthy apical region (region 2) is estimated with a very narrow uni-modal
distribution with a mode of 0.142. Interestingly, several regions in the lateral
RV (region 4, 5, and 7) show very high uncertainty with a distribution of
the parameter value extending from healthy to infarct range. Overall, results
show an estimate of healthy tissue in the apical region with high confidence,
an estimate of heterogeneous tissue with infarct at lateral LV with medium
confidence (Fig. 6.9(c)), and an estimate of the ambiguous region in lateral
RV as healthy with high uncertainty.
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Figure 6.12: Real-data experiments for case 3 from Fig. 6.9. (a) Regions of the heart
to be parameterized. (b) Univariate and bivariate marginal pdf plots.
6.6 Discussion
6.6.1 Effect of the Gaussian Proposal Distribution
The effect of the Gaussian proposal distribution on the presented GP-accelerated
MH is similar to that on the standard MH. A narrow proposal distribution
takes small steps in the sampling space, resulting in a high acceptance rate
but slower mixing. By contrast, a wide proposal distribution takes wide steps
in the sampling space, resulting in a low acceptance rate but fast mixing.
As shown in Fig. 6.13(a), as the width of the Gaussian proposal distribution
increases, the acceptance rate of the presented framework decreases.
When using the standard MH for higher dimensional posterior pdfs, a pro-
posal distribution that results in an acceptance rate of ∼ 0.22 is documented
to enable good mixing and faster convergence [3,33]. However, tuning the pro-
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Figure 6.13: Acceptance rate of the GP-accelerated MH method: (a) decreases
as the width (standard deviation) of the Gaussian proposal increases, (b) decreases
as the Kullback-Leibler divergence from the GP surrogate to the exact posterior pdf
increases. Data is taken from the sampled distributions in synthetic data experiments.
posal distribution to obtain a good acceptance rate by repeated trial-and-error
sampling of the exact posterior pdf is impossible here due to high computa-
tional cost. In this study, assuming that the GP surrogate pdf captures the
shape of the exact posterior pdf, we leverage the efficiency of the surrogate pdf
and tune the proposal distribution by rapidly sampling the GP surrogate pdf.
Similarly, as described earlier, the starting point for each of the parallel MC
chains is also initialized from fast sampling of the GP surrogate pdf. In other
words, the GP surrogate not only accelerates the MH through the two-stage
sampling scheme, but also allows for fast tuning of the proposal distribution
and selection of initial samples. For a fair evaluation of the efficacy of the
presented GP-accelerated MH method, the tuned proposal distribution and
initial samples were used with both the direct MH and GP-accelerated MH in
the presented experiments.
6.6.2 Quality of the Surrogate vs. Acceptance Rate
To understand how the acceptance rate of the presented GP-accelerated MH
method is related to the accuracy of the GP surrogate, we measure the quality
of the GP surrogates built in the synthetic data experiments by their Kullback-
Leibler (KL) divergence to the exact posterior pdfs. The KL-divergence from
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Because above KL divergence cannot be obtained analytically, we estimate















where θi are N random samples of π(θ|Y) obtained from direct MH method.
As shown in Fig. 6.13(b), in most cases, the KL divergence of the surrogate
pdf is low, indicating a high accuracy of the surrogate pdf. However, some
surrogate pdfs had a high KL divergence from the exact pdf, indicating lim-
ited accuracy which is most likely related to the increased complexity in the
shape of the unnormalized log exact posterior pdf. As expected, a negative
correlation between the quality of the GP surrogate and the acceptance rate
of the GP-accelerated MH method (correlation coefficient = -0.777) can be
observed in Fig. 6.13(b). In other words, a more accurate GP surrogate will
result in a higher efficiency of the presented sampling method, whereas a less
accurate GP surrogate would be less effective in accelerating the MH sam-
pling. However, a more accurate GP surrogate would also be more expensive
to construct, whereas a less accurate one would be faster to construct. How
to balance between these two steps, as well as how to construct an accurate
surrogate without evoking a large number of model evaluations, are to be
investigated in future works.
6.6.3 Related Works
Related works on uncertainty quantification in personalized models can be
broadly categorized into two types: 1) forward uncertainty quantification,
and 2) inverse uncertainty quantification. Forward uncertainty quantification
focuses on the uncertainty in model output as a result of variations in differ-
ent model parameters. To overcome the challenge of repeatedly evaluating the
expensive simulation model, methods such as generalized polynomial chaos or
stochastic collocation are commonly used. In the domain of electrocardiogra-
phy, this includes examples such as the study of sensitivity of model output to
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conductivity parameters [31], the study of sensitivity of measured ECG signals
on heart motion [73], and the study of sensitivity of ECG signal components
as a result of variations in sub-endocardial ischemia [37]. These works are
fundamentally different from the presented work that focuses on the inverse
uncertainty quantification.
The inverse uncertainty quantification focuses on the uncertainty within
the model (such as the estimated model parameters) as a result of differ-
ent uncertain factors involved in the personalization of the model. Among
existing works, the approach presented in [46], although applied to a brain
tumor growth model, is most common in its spirit with the presented frame-
work. Specifically, the work presented in [46] also utilizes a two stage sampling
method (GPHMC) in which first a GP surrogate of the unnormalized nega-
tive log posterior pdf is learned with HMC and then its gradient is utilized
in HMC for efficient sampling. To compare the presented method and the
GPHMC method, we conducted experiments on six synthetic cases. Imple-
mentation of the GPHMC method as detailed in [46] is utilized. We take 50
initialization points and 3000 exploratory points during the construction of
the GP surrogate. The comparison is presented with respect to the two major
elements of these methods: 1) GP surrogate construction, and 2) posterior
pdf sampling. For the constructed GP surrogates, their mean KL divergences
to the exact posterior pdf are respectively 6.58 and 38.57 for the presented
method and the GPHMC method. This gain in accuracy by the presented
method could be because of the utilization of a Matérn 5/2 kernel in GP, and
an active scheme with a derivative free deterministic optimization to select
training points. An increase in the number of training points in the GPHMC
method may increase the accuracy of the GP surrogate. For the posterior pdf
sampling, surprisingly we observed an acceptance rate of ≤ 0.1 with GPHMC
although the accuracy of the GP surrogate was comparable between the two
methods. We speculate that given the non-smooth and complex shape of
the negative log posterior pdf and its first derivative in this study, a GP –
especially one with a squared exponential kernel that assumes an infinitely
differentiable prior over the negative log posterior pdf – could not accurately
approximate its local derivatives. This inaccuracy in the approximated local
derivatives may then lead to poor candidate samples proposed by the HMC,
resulting in low acceptance rate. In contrast, because the presented method
only depends on the approximate global shape of the log posterior pdf without
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utilizing its derivative information in the sampling, a smoother approximation
such as a GP with Matérn 5/2 kernel could increase the acceptance rate.
The selection of points for the construction of a GP surrogate shares com-
mon intuition with active learning [40], Bayesian optimization [7], and multi-
armed bandits problems [71] in which based on a history of actions and
rewards a decision needs to be made on the next best point to query from
the solution space. More recently, there has been an interest in utilizing these
methods to approximate intractable pdfs [39]. In contrast to these works that
focus on obtaining a surrogate model that can directly replace the exact pdf,
the presented framework focuses on utilizing this surrogate to accelerate the
sampling without a compromise in accuracy.
6.7 Conclusion
In this study, we presented a novel framework to efficiently yet accurately
sample the posterior distribution of parameters in patient-specific cardiac elec-
trophysiological models. This is achieved by first an active construction of an
efficient GP surrogate of the posterior pdf, followed by the use of this surro-
gate to improve the proposal distribution of the standard MH. The presented
method is evaluated on both synthetic and real data experiments. The future
work will investigate methods to further improve the accuracy of the surrogate
model, without requiring a large number of model evaluations.
Chapter 7
Conclusion and Future Work
While computational modeling and medical imaging technologies have made
tremendous progress in the past few decades there are still many unresolved
hurdles to estimating the model parameters along with their uncertainties [74].
The Bayesian active surrogate learning based approaches presented in this dis-
sertation aims at taking us a step forward in this direction by addressing the as-
sociated challenges of high-computational cost and high input-dimensionality
in model personalization and uncertainty quantification. In clinical and scien-
tific study of cardiac diseases and disease mechanisms, uncertainty measures
of modeling components or the model output are very important. The uncer-
tainty in model prediction provides a measure of the quality of the prediction
and helps to quantify the reliability of the model. The uncertainty also pro-
vide various knowledge about the modeling components such as unidentifiable
parameters and interactions/correlations between the various modeling com-
ponents. Finally, the uncertainty measure can also provide knowledge to the
scientists and clinician on what additional data needs to be collected or what
modeling component needs to be improved to improve the reliability of the
model.
This dissertation focuses on Bayesian active learning approaches in appli-
cation to cardiac model personalization and uncertainty quantification. To
handle the existing challenge of learning a surrogate of a complex function
defined over a high-dimensional (HD) unknown space of model parameters
we presented two fundamental contributions in Bayesian active learning: a
multi-scale surrogate-based optimization with adaptive spatial refinement de-
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cision criteria and a generative variational auto-encoder (VAE) enabled high-
dimensional (HD) Bayesian optimization. The actively learned surrogate of
the expensive objective function was used for efficient parameter optimization
in Chapters 3-5. Finally, in Chapter 6 a novel approach to utilize the surro-
gate of an unknown posterior density function in accelerating its Metropolis-
Hastings sampling was presented. Future research directions are listed below:
7.1 Limitations
Recent developments in multi-scale cardiac simulation models, medical imag-
ing technologies and high-performance computing resources have enabled enor-
mous progress in personalized cardiac simulation models. These models have
shown increasing capability in surgical planning, design and experimenta-
tion on medical devices, and understanding various cardiac disease mecha-
nism [65, 68, 74]. However, there are still various limitations of personalized
model, especially in relation to their clinical adoptions. Below we detail some
limitations in specific to the personalized models presented in this dissertation
work.
One major limitation of the approaches presented here is that they were
tested on a simple two-variable phenomenological model called the Aliev-
Panfilov model. While this model offers a faster execution time and the key
macroscopic insights of cardiac activation, it does not offer detailed insights of
microscopic ionic activity and cellular kinetics. Furthermore, the anatomical
model lacks various details present in a human heart. For example, the fibers
are mapped from a simple canine heart model, his bundle branches and purk-
inje systems are absent, and the temporal change in anatomy is ignored. In
summary, the physiological model used in this paper lacks details in order to
faithfully explain complicated disease mechanisms or ion channel interactions.
Another important limitation of personalizing physiological models and
quantifying uncertainty in these models is the huge computational-cost asso-
ciated with them. A single evaluation of the physiological model can take
minutes or hours to run in a high performance computing system. Personal-
ization and uncertainty quantification requires a large number of runs (in a
range of thousands or millions) of these models making them computationally
very expensive. This also restricts their application in clinical setting where
a quick decision is needed. This thesis presented various approaches to re-
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duce the computational cost of uncertainty quantification and personalization
primarily through building and using an efficient surrogate model. However,
there is much room for further improvement in this regard.
Currently there are various difficulties in the clinical adoption of the per-
sonalized cardiac models [74]. One important challenge in terms of their use
in clinical cardiology is that these models can produce variability in outcomes
across the temporal and spatial scales. The main goal of the Bayesian ac-
tive surrogate learning approaches developed in these paper is to be able to
capture these uncertainties. Therefore, as a preliminary investigation of the
feasibility of these methods, these methods have been extensively evaluated
on synthetic and real data. However, they have not been studied in clinical
setting with clinician. These methods have not been validated for clinical use.
A future extension is to investigate these approaches with a multi-scale model
and validate them with clinical and experimental data. This naturally means
that the models and these methods need to be deployed with high-performance
computing resources.
7.2 Future Work
Quantification of the uncertainty in model parameters that are esti-
mated by using a generative VAE model for low-to-high dimensional
mapping: One immediate future direction is to explore the integration of
the HD Bayesian optimization via an embedded VAE method presented in
Chapter 5 with the uncertainty quantification framework presented in Chap-
ter 6. The goal is to quantify the uncertainty in estimated model parameters
arising from both measurement errors and the low-dimensional representation
of model parameters obtained with a generative model.
Bayesian active learning beyond Gaussian processes: A standard Gaus-
sian process is useful in modeling a stationary process. In future, one impor-
tant direction is to investigate various alternatives to Gaussian process in
Bayesian active learning such as a deep Gaussian process or a non-linear neu-
ral net. These alternatives should be able to capture functions with complex
and non-stationary properties.
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Improvement of the generalization ability of VAE: Another future
direction is to improve the generalization ability of the VAE to generalize to
realistic conditions where tissue abnormality is more complex in terms of the
shape, transmurality, and heterogeneity. To this end, the first step is to inves-
tigate the limitation on the accuracy of the estimated parameters contributed
by the generative model vs. that contributed by indirect measurements. Next
steps are to use realistic training data from high resolution 3D imaging to
train a more expressive generative model and to investigate further strategies
to improve VAE generalization.
Transfer learning and life-long learning of the generative model:
Chapter 5 presented an initial study that showed the feasibility of transfer
learning in a graph convolutional VAE. Because medical data comprising of
spatially varying tissue properties are not readily available a future work is to
investigate ways to enable accurate transfer learning and life long learning in
a graph convolutional VAE.
Generalization beyond the application of cardiac model personal-
ization: Complex and costly objective functions are common in various do-
mains [1,15,16,80]. A future direction is to validate the presented approaches
in various applications that involve simulation models beyond a cardiac elec-
trophysiological model.
Uncertainty quantification in forward models: The forward model con-
sisting of the complex and computationally expensive physiological model itself
has many important applications. For example, it has been used for surgical
planning, medical device design, and understanding biomechanics of cardio-
vascular disease progression [4,5,36,50,74]. This dissertation revolves around
the surrogate modeling of a complex function that can be utilized in uncer-
tainty quantification. Therefore, a future direction is to extend the presented
Bayesian active surrogate learning approaches in the uncertainty quantifica-
tion of the forward models. The uncertainty obtained in this manner can help
scientists to understand the reliability of the model’s prediction, to quantify
the risk associated with model’s prediction, to determine what additional data
needs to be collected, and to determine what modelling element needs to be
improved.
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Uncertainty quantification of image-based personalized model: Image-
based personalized simulation models have shown promising results in im-
portant clinical problems [4, 68, 74]. While these approaches differ from the
presented approaches by using the patient’s medical images instead of the
physiological signals for model personalization, they share the challenge of
having a complex simulation model in the forward model. Therefore, a fu-
ture direction is to extend the Bayesian active surrogate learning of a complex
function discussed in this dissertation to these image-based personalization
strategies. One direct extension is to investigate surrogate based uncertainty
quantification to quantify the uncertainties arising from scar segmentation and
thresholds used to assign tissue types in imaged-based personalized models.
The quantification of this uncertainty can provide scientists and clinicians a
measure of quality associated with the model’s prediction and helps them in
informed decision-making.
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